Arthur Moss
| Title | Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Medicine |
|---|
| Address | Heart Research Follow-up Program
265 Crittenden Blvd.
Rochester NY 14642
|
|---|
|
|
|
| 1962 |
-
| 1966 | Research Fellowship: American Heart Association Advanced Research Fellow | | 1962 |
|
| Research Prize: Monroe County Medical Society Prize Award | | 1976 |
|
| University of Rochester School of Medicine Alumni Gold Medal Award |
-
Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, Moss AJ. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA. 2013 Jan 2; 309(1):55-62.
-
Tisma-Dupanovic S, Wagner JB, Shah S, Huang DT, Moss AJ. An Adolescent with Possible Arrhythmogenic Right Ventricular Dysplasia and Long QT Syndrome: Evaluation and Management. Ann Noninvasive Electrocardiol. 2013 Jan; 18(1):75-8.
-
Hoefen R, Reumann M, Goldenberg I, Moss AJ, O-Uchi J, Gu Y, McNitt S, Zareba W, Jons C, Kanters JK, Platonov PG, Shimizu W, Wilde AA, Rice JJ, Lopes CM. In Silico Cardiac Risk Assessment in Patients With Long QT Syndrome: Type 1: Clinical Predictability of Cardiac Models. J Am Coll Cardiol. 2012 Nov 20; 60(21):2182-91.
-
Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NA, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012 Dec 13; 367(24):2275-83.
-
Kutyifa V, Zareba W, McNitt S, Singh J, Hall WJ, Polonsky S, Goldenberg I, Huang DT, Merkely B, Wang PJ, Moss AJ, Klein H. Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial. Eur Heart J. 2013 Jan; 34(3):184-90.
-
Veazie PJ, Noyes K, Li Q, Hall WJ, Buttaccio A, Thevenet-Morrison K, Moss AJ. Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure. J Am Coll Cardiol. 2012 Nov 6; 60(19):1940-4.
-
Ouellet G, Huang DT, Moss AJ, Hall WJ, Barsheshet A, McNitt S, Klein H, Zareba W, Goldenberg I. Effect of Cardiac Resynchronization Therapy on the Risk of First and Recurrent Ventricular Tachyarrhythmic Events in MADIT-CRT. J Am Coll Cardiol. 2012 Oct 30; 60(18):1809-16.
-
Moss AJ. Selection of high-risk patients for device intervention with the new advances in technology. J Electrocardiol. 2012 Nov; 45(6):670-2.
-
Noyes K, Veazie P, Hall WJ, Zhao H, Buttaccio A, Thevenet-Morrison K, Moss AJ. Cost-Effectiveness of Cardiac Resynchronization Therapy in the MADIT-CRT Trial. J Cardiovasc Electrophysiol. 2013 Jan; 24(1):66-74.
-
Brenyo A, Pietrasik G, Barsheshet A, Huang DT, Polonsky B, McNitt S, Moss AJ, Zareba W. QRS Fragmentation and the Risk of Sudden Cardiac Death in MADIT II. J Cardiovasc Electrophysiol. 2012 Dec; 23(12):1343-8.
-
Schuger C, Daubert JP, Brown MW, Cannom D, Estes NA, Hall WJ, Kayser T, Klein H, Olshansky B, Power KA, Wilber D, Zareba W, Moss AJ. Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol. Ann Noninvasive Electrocardiol. 2012 Jul; 17(3):176-85.
-
Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E. Predictors of Super-Response to Cardiac Resynchronization Therapy and Associated Improvement in Clinical Outcome: The MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) Study. J Am Coll Cardiol. 2012 Jun 19; 59(25):2366-73.
-
Buber J, Goldenberg I, Moss AJ, Wang PJ, McNitt S, Hall WJ, Eldar M, Barsheshet A, Shechter M. Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2012 Aug 21; 60(8):749-55.
-
Barsheshet A, Moss AJ, Huang DT, McNitt S, Zareba W, Goldenberg I. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol. 2012 Jun 5; 59(23):2075-9.
-
Couderc JP, Xia X, Denjoy I, Extramiana F, Maison-Blanche P, Moss AJ, Zareba W, Lopes CM. Genotype- and Sex-Specific QT-RR Relationship in the Type-1 Long-QT Syndrome. J Am Heart Assoc. 2012 Apr; 1(2):e000570.
-
Brenyo A, Goldenberg I, Moss AJ, Rao M, McNitt S, Huang DT, Zareba W, Barsheshet A. Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT. Heart Rhythm. 2012 Sep; 9(9):1454-9.
-
Barsheshet A, Goldenberg I, O-Uchi J, Moss AJ, Jons C, Shimizu W, Wilde AA, McNitt S, Peterson DR, Zareba W, Robinson JL, Ackerman MJ, Cypress M, Gray DA, Hofman N, Kanters JK, Kaufman ES, Platonov PG, Qi M, Towbin JA, Vincent GM, Lopes CM. Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events: Implications for Mutation-Specific Response to ß-Blocker Therapy in Type 1 Long-QT Syndrome. Circulation. 2012 Apr 24; 125(16):1988-96.
-
Barsheshet A, Brenyo A, Goldenberg I, Moss AJ. Sex-related differences in patients' responses to heart failure therapy. Nat Rev Cardiol. 2012; 9(4):234-42.
-
Costa J, Lopes CM, Barsheshet A, Moss AJ, Migdalovich D, Ouellet G, McNitt S, Polonsky S, Robinson JL, Zareba W, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Goldenberg I. Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. Heart Rhythm. 2012 Jun; 9(6):892-8.
-
Moss AJ. Sex hormones and ventricular tachyarrhythmias in LQTS: New insights regarding antiarrhythmic therapy. Heart Rhythm. 2012 May; 9(5):833-4.
-
Moss AJ. What's Past Is Prologue: A 2012 Update. Ann Noninvasive Electrocardiol. 2012 Jan; 17(1):1-2.
-
George J, Barsheshet A, Moss AJ, Martin D, Ouellet G, McNitt S, Goldenberg I. Effectiveness of cardiac resynchronization therapy in diabetic patients with ischemic and nonischemic cardiomyopathy. Ann Noninvasive Electrocardiol. 2012 Jan; 17(1):14-21.
-
Corsetti JP, Ryan D, Moss AJ, McCarthy J, Goldenberg I, Zareba W, Sparks CE. Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels. Thromb Haemost. 2011 Nov 30; 106(6):1170-8.
-
Brenyo A, Link MS, Barsheshet A, Moss AJ, Zareba W, Wang PJ, McNitt S, Huang D, Foster E, Estes M, Solomon SD, Goldenberg I. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011 Oct 11; 58(16):1682-9.
-
Barsheshet A, Brenyo A, Moss AJ, Goldenberg I. Genetics of sudden cardiac death. Curr Cardiol Rep. 2011 Oct; 13(5):364-76.
-
A statement on ethics from the HEART group. Ann Noninvasive Electrocardiol. 2011 Oct; 16(4):418-20.
-
Goldenberg I, Moss AJ, Hall WJ, Foster E, Goldberger JJ, Santucci P, Shinn T, Solomon S, Steinberg JS, Wilber D, Barsheshet A, McNitt S, Zareba W, Klein H. Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011 Oct 4; 124(14):1527-36.
-
Rao M, Goldenberg I, Moss AJ, Klein H, Huang DT, Bianco NR, Szymkiewicz SJ, Zareba W, Brenyo A, Buber J, Barsheshet A. Wearable defibrillator in congenital structural heart disease and inherited arrhythmias. Am J Cardiol. 2011 Dec 1; 108(11):1632-8.
-
Goldenberg I, Thottathil P, Lopes CM, Moss AJ, McNitt S, O-Uchi J, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Towbin JA, Vincent M, Barsheshet A. Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome. Heart Rhythm. 2012 Jan; 9(1):49-56.
-
Adabag S, Roukoz H, Anand IS, Moss AJ. Cardiac resynchronization therapy in patients with minimal heart failure: a systematic review and meta-analysis. J Am Coll Cardiol. 2011 Aug 23; 58(9):935-41.
-
Barsheshet A, Moss AJ, McNitt S, Polonsky S, Lopes CM, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Towbin JA, Vincent GM, Qi M, Goldenberg I. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation. Circ Cardiovasc Genet. 2011 Oct; 4(5):491-9.
-
Goldenberg I, Hall WJ, Beck CA, Moss AJ, Barsheshet A, McNitt S, Polonsky S, Brown MW, Zareba W. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011 Aug 9; 58(7):729-37.
-
Penn J, Goldenberg I, Moss AJ, McNitt S, Zareba W, Klein HU, Cannom DS, Solomon SD, Barsheshet A, Huang DT. Improved outcome with preventive cardiac resynchronization therapy in the elderly: a MADIT-CRT substudy. J Cardiovasc Electrophysiol. 2011 Aug; 22(8):892-7.
-
Barsheshet A, Wang PJ, Moss AJ, Solomon SD, Al-Ahmad A, McNitt S, Foster E, Huang DT, Klein HU, Zareba W, Eldar M, Goldenberg I. Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011 Jun 14; 57(24):2416-23.
-
Buber J, Klein H, Moss AJ, McNitt S, Eldar M, Padeletti L, Vogt J, Meine M, Brown MW, Barsheshet A, Zareba W, Goldenberg I. Clinical course and outcome of patients enrolled in US and non-US centres in MADIT-CRT. Eur Heart J. 2011 Nov; 32(21):2697-704.
-
Buber J, Mathew J, Moss AJ, Hall WJ, Barsheshet A, McNitt S, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Luria D, Eldar M, Towbin JA, Vincent M, Goldenberg I. Risk of recurrent cardiac events after onset of menopause in women with congenital long-QT syndrome types 1 and 2. Circulation. 2011 Jun 21; 123(24):2784-91.
-
Goldberger JJ, Buxton AE, Cain M, Costantini O, Exner DV, Knight BP, Lloyd-Jones D, Kadish AH, Lee B, Moss A, Myerburg R, Olgin J, Passman R, Rosenbaum D, Stevenson W, Zareba W, Zipes DP. Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks. Circulation. 2011 May 31; 123(21):2423-30.
-
Barsheshet A, Goldenberg I, Moss AJ, Huang DT, Zareba W, McNitt S, Klein HU, Guetta V. Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long-Term Survival in the MADIT-II Trial. J Cardiovasc Electrophysiol. 2011 Nov; 22(11):1237-42.
-
Pouleur AC, Knappe D, Shah AM, Uno H, Bourgoun M, Foster E, McNitt S, Hall WJ, Zareba W, Goldenberg I, Moss AJ, Pfeffer MA, Solomon SD. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J. 2011 Jul; 32(14):1720-9.
-
Knappe D, Pouleur AC, Shah AM, Cheng S, Uno H, Hall WJ, Bourgoun M, Foster E, Zareba W, Goldenberg I, McNitt S, Pfeffer MA, Moss AJ, Solomon SD. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail. 2011 Jul; 4(4):433-40.
-
A statement on ethics from the HEART Group. Anadolu Kardiyol Derg. 2011 Jun; 11(4):363-5.
-
Jons C, O-Uchi J, Moss AJ, Reumann M, Rice JJ, Goldenberg I, Zareba W, Wilde AA, Shimizu W, Kanters JK, McNitt S, Hofman N, Robinson JL, Lopes CM. Use of mutant-specific ion channel characteristics for risk stratification of long QT syndrome patients. Sci Transl Med. 2011 Mar 30; 3(76):76ra28.
-
Migdalovich D, Moss AJ, Lopes CM, Costa J, Ouellet G, Barsheshet A, McNitt S, Polonsky S, Robinson JL, Zareba W, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Goldenberg I. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. Heart Rhythm. 2011 Oct; 8(10):1537-43.
-
Barsheshet A, Peterson DR, Moss AJ, Schwartz PJ, Kaufman ES, McNitt S, Polonsky S, Buber J, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Towbin JA, Vincent GM, Zhang L, Goldenberg I. Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome. Heart Rhythm. 2011 Aug; 8(8):1207-13.
-
Singh JP, Klein HU, Huang DT, Reek S, Kuniss M, Quesada A, Barsheshet A, Cannom D, Goldenberg I, McNitt S, Daubert JP, Zareba W, Moss AJ. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation. 2011 Mar 22; 123(11):1159-66.
-
Moss AJ, Francis CW, Ryan D. Collaborative clinical trials. N Engl J Med. 2011 Mar 3; 364(9):789-91.
-
Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M, Cannom D, Daubert JP, Eldar M, Gold MR, Goldberger JJ, Goldenberg I, Lichstein E, Pitschner H, Rashtian M, Solomon S, Viskin S, Wang P, Moss AJ. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011 Mar 15; 123(10):1061-72.
-
Martin DT, McNitt S, Nesto RW, Rutter MK, Moss AJ. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT). Circ Heart Fail. 2011 May; 4(3):332-8.
-
Liu JF, Jons C, Moss AJ, McNitt S, Peterson DR, Qi M, Zareba W, Robinson JL, Barsheshet A, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin J, Vincent M, Zhang L, Goldenberg I. Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents With Long QT Syndrome. J Am Coll Cardiol. 2011 Feb 22; 57(8):941-50.
-
Arshad A, Moss AJ, Foster E, Padeletti L, Barsheshet A, Goldenberg I, Greenberg H, Hall WJ, McNitt S, Zareba W, Solomon S, Steinberg JS. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol. 2011 Feb 15; 57(7):813-20.
-
Couderc JP, Xia X, Peterson DR, McNitt S, Zhao H, Polonsky S, Moss AJ, Zareba W. T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition. Heart Rhythm. 2011 Jul; 8(7):1036-43.
-
Horr S, Goldenberg I, Moss AJ, O-Uchi J, Barsheshet A, Connelly H, Gray DA, Zareba W, Lopes CM. Ion channel mechanisms related to sudden cardiac death in phenotype-negative long-QT syndrome genotype-phenotype correlations of the KCNQ1(S349W) mutation. J Cardiovasc Electrophysiol. 2011 Feb; 22(2):193-200.
-
Goldenberg I, Horr S, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Platonov PG, Priori SG, Qi M, Schwartz PJ, Shimizu W, Towbin JA, Vincent GM, Wilde AA, Zhang L. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. J Am Coll Cardiol. 2011 Jan 4; 57(1):51-9.
-
Moss AJ. The ins and the outs of cardiac dyssynchrony. Ann Noninvasive Electrocardiol. 2011 Jan; 16(1):1-2.
-
A statement on ethics from the HEART group. Ann Noninvasive Electrocardiol. 2011 Jan; 16(1):107-9.
-
Lane RD, Zareba W, Reis HT, Peterson DR, Moss AJ. Changes in ventricular repolarization duration during typical daily emotion in patients with Long QT syndrome. Psychosom Med. 2011 Jan; 73(1):98-105.
-
Moss AJ. Preventing heart failure and improving survival. N Engl J Med. 2010 Dec 16; 363(25):2456-7.
-
Barsheshet A, Moss AJ, Eldar M, Huang DT, Hall WJ, Klein HU, McNitt S, Steinberg JS, Wilber DJ, Zareba W, Goldenberg I. Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction. Eur Heart J. 2011 Jul; 32(13):1614-21.
-
Barsheshet A, Goldenberg I, Moss AJ, Eldar M, Huang DT, McNitt S, Klein HU, Hall WJ, Brown MW, Goldberger JJ, Goldstein RE, Schuger C, Zareba W, Daubert JP. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J. 2011 Jul; 32(13):1622-30.
-
Sze E, Moss AJ, McNitt S, Barsheshet A, Andrews ML, Zareba W, Goldenberg I. Risk factors for recurrent heart failure events in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Cardiovasc Electrophysiol. 2010 Nov; 21(11):1217-23.
-
Zhang T, Moss A, Cong P, Pan M, Chang B, Zheng L, Fang Q, Zareba W, Robinson J, Lin C, Li Z, Wei J, Zeng Q. LQTS gene LOVD database. Hum Mutat. 2010 Nov; 31(11):E1801-10.
-
Barsheshet A, Moss AJ, McNitt S, Jons C, Glikson M, Klein HU, Huang DT, Steinberg JS, Brown MW, Zareba W, Goldenberg I. Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm. 2011 Feb; 8(2):212-8.
-
Moss AJ. Hereditary arrhythmia corner: learning from challenging patients: a new section of Annals. Ann Noninvasive Electrocardiol. 2010 Oct; 15(4):299-300.
-
Moss AJ. Fragmented QRS: the new high-risk kid on the block in acquired long QT syndrome. Heart Rhythm. 2010 Dec; 7(12):1815-6.
-
Kim JA, Lopes CM, Moss AJ, McNitt S, Barsheshet A, Robinson JL, Zareba W, Ackerman MJ, Kaufman ES, Towbin JA, Vincent M, Goldenberg I. Trigger-specific risk factors and response to therapy in long QT syndrome type 2. Heart Rhythm. 2010 Dec; 7(12):1797-805.
-
Goldenberg I, Moss AJ, McNitt S, Barsheshet A, Gray D, Andrews ML, Brown MW, Zareba W, Sze E, Solomon SD, Pfeffer MA. Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm. 2010 Dec; 7(12):1777-82.
-
Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation. 2010 Sep 28; 122(13):1265-71.
-
Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, Pfeffer MA, Moss AJ. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation. 2010 Sep 7; 122(10):985-92.
-
Barsheshet A, Goldenberg I, Narins CR, Moss AJ, McNitt S, Wang PJ, Huang DT, Hall WJ, Zareba W, Eldar M, Guetta V. Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT. Heart Rhythm. 2010 Oct; 7(10):1421-7.
-
Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Sparks CE. Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels. Arterioscler Thromb Vasc Biol. 2010 Aug; 30(8):1657-64.
-
Moss AJ. What we have learned from the family of multicenter automatic defibrillator implantation trials. Circ J. 2010 Jun; 74(6):1038-41.
-
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet. 2010 May 1; 375(9725):1536-44.
-
Case RB, Moss AJ. Recommendation for revision of the standard presentation of the frontal plane ECG leads including reversal of lead aVR (to -aVR): It is time for a change. Ann Noninvasive Electrocardiol. 2010 Apr; 15(2):97-100.
-
Goldenberg I, Bradley J, Moss A, McNitt S, Polonsky S, Robinson JL, Andrews M, Zareba W. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol. 2010 Aug 1; 21(8):893-901.
-
Jons C, Moss AJ, Goldenberg I, Liu J, McNitt S, Zareba W, Qi M, Robinson JL. Risk of fatal arrhythmic events in long QT syndrome patients after syncope. J Am Coll Cardiol. 2010 Feb 23; 55(8):783-8.
-
Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction. Am J Cardiol. 2010 Mar 1; 105(5):581-6.
-
Liu JF, Moss AJ, Jons C, Benhorin J, Schwartz PJ, Spazzolini C, Crotti L, Ackerman MJ, McNitt S, Robinson JL, Qi M, Goldenberg I, Zareba W. Mutation-specific risk in two genetic forms of type 3 long QT syndrome. Am J Cardiol. 2010 Jan 15; 105(2):210-3.
-
Moss AJ. Gender differences in ECG parameters and their clinical implications. Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):1-2.
-
Holmqvist F, Platonov PG, McNitt S, Polonsky S, Carlson J, Zareba W, Moss AJ. Abnormal P-wave morphology is a predictor of atrial fibrillation development and cardiac death in MADIT II patients. Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):63-72.
-
Fugate T, Moss AJ, Jons C, McNitt S, Mullally J, Ouellet G, Goldenberg I, Zareba W, Robinson JL. Long QT syndrome in African-Americans. Ann Noninvasive Electrocardiol. 2010 Jan; 15(1):73-6.
-
Moss AJ, Goldenberg I. Prevention of sudden cardiac death: need for a plaque stabilizer. Am Heart J. 2010 Jan; 159(1):15-6.
-
Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, Shah A, Taylor S, McNitt S, Moss AJ, Zareba W, Huang DT. Time-dependent risk of Fidelis lead failure. Am J Cardiol. 2010 Jan 1; 105(1):95-9.
-
Shimizu W, Moss AJ, Wilde AA, Towbin JA, Ackerman MJ, January CT, Tester DJ, Zareba W, Robinson JL, Qi M, Vincent GM, Kaufman ES, Hofman N, Noda T, Kamakura S, Miyamoto Y, Shah S, Amin V, Goldenberg I, Andrews ML, McNitt S. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol. 2009 Nov 24; 54(22):2052-62.
-
Klein HU, Meltendorf U, Reek S, Smid J, Kuss S, Cygankiewicz I, Jons C, Szymkiewicz S, Buhtz F, Wollbrueck A, Zareba W, Moss AJ. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010 Mar; 33(3):353-67.
-
Ouellet G, Moss AJ, Jons C, McNitt S, Mullally J, Fugate T, Goldenberg I, Zareba W, Robinson JL. Influence of diabetes mellitus on outcome in patients over 40 years of age with the long QT syndrome. Am J Cardiol. 2010 Jan 1; 105(1):87-9.
-
Moss AJ. QRS duration in the selection of patients for cardiac resynchronization therapy. Ann Noninvasive Electrocardiol. 2009 Oct; 14(4):317-8.
-
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009 Oct 1; 361(14):1329-38.
-
Spazzolini C, Mullally J, Moss AJ, Schwartz PJ, McNitt S, Ouellet G, Fugate T, Goldenberg I, Jons C, Zareba W, Robinson JL, Ackerman MJ, Benhorin J, Crotti L, Kaufman ES, Locati EH, Qi M, Napolitano C, Priori SG, Towbin JA, Vincent GM. Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy. J Am Coll Cardiol. 2009 Aug 25; 54(9):832-7.
-
Holmqvist F, Platonov PG, Carlson J, Zareba W, Moss AJ. Altered interatrial conduction detected in MADIT II patients bound to develop atrial fibrillation. Ann Noninvasive Electrocardiol. 2009 Jul; 14(3):268-75.
-
Block R, Corsetti J, Goldenberg I, Vorobiof G, McNitt S, Ryan D, Zareba W, Moss AJ. The common apolipoprotein A-1 polymorphism -75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction. Heart Int. 2009 Jun 30; 4(1):e8.
-
Lane RD, Reis HT, Peterson DR, Zareba W, Moss AJ. Happiness and stress alter susceptibility to cardiac events in Long QT Syndrome. Ann Noninvasive Electrocardiol. 2009 Apr; 14(2):193-200.
-
Jons C, Moss AJ, Lopes CM, McNitt S, Zareba W, Goldenberg I, Qi M, Wilde AA, Shimizu W, Kanters JK, Towbin JA, Ackerman MJ, Robinson JL. Mutations in conserved amino acids in the KCNQ1 channel and risk of cardiac events in type-1 long-QT syndrome. J Cardiovasc Electrophysiol. 2009 Aug; 20(8):859-65.
-
Hunter JV, Moss AJ. Seizures and arrhythmias: Differing phenotypes of a common channelopathy? Neurology. 2009 Jan 20; 72(3):208-9.
-
Heilman RL, Chakkera H, Mazur M, Petrides S, Moss A, Mekeel K, Mulligan D, Reddy KS. Outcomes of simultaneous kidney-pancreas transplantation with positive cross-match. Transplant Proc. 2009 Jan-Feb; 41(1):303-6.
-
Moss AJ, O'Connor DJ, Pulerwitz L, Engle RP, Singleton JW, Crum A. Making medical education more affordable. Ann Noninvasive Electrocardiol. 2009 Jan; 14(1):93-5.
-
Noyes K, Corona E, Veazie P, Dick AW, Zhao H, Moss AJ. Examination of the effect of implantable cardioverter-defibrillators on health-related quality of life: based on results from the Multicenter Automatic Defibrillator Trial-II. Am J Cardiovasc Drugs. 2009; 9(6):393-400.
-
Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H, McNitt S, Polonsky S, Andrews M, Dwyer EM, Hall WJ, Moss AJ. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm. 2009 Apr; 6(4):468-73.
-
Haigney MC, Zareba W, Nasir JM, McNitt S, McAdams D, Gentlesk PJ, Goldstein RE, Moss AJ. Gender differences and risk of ventricular tachycardia or ventricular fibrillation. Heart Rhythm. 2009 Feb; 6(2):180-6.
-
Goldenberg I, Zareba W, Moss AJ. Long QT Syndrome. Curr Probl Cardiol. 2008 Nov; 33(11):629-94.
-
Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators. J Cardiovasc Electrophysiol. 2009 Apr; 20(4):395-400.
-
Corsetti JP, Ryan D, Rainwater DL, Moss AJ, Zareba W, Block RC, Sparks CE. Lp(a) and risk of recurrent cardiac events in obese postinfarction patients. Obesity (Silver Spring). 2008 Dec; 16(12):2717-22.
-
Sze E, Moss AJ, Goldenberg I, McNitt S, Jons C, Zareba W, Qi M, Robinson JL. Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease. Ann Noninvasive Electrocardiol. 2008 Oct; 13(4):327-31.
-
Goldenberg I, Moss AJ. Implantable cardioverter defibrillator efficacy and chronic kidney disease: competing risks of arrhythmic and nonarrhythmic mortality. J Cardiovasc Electrophysiol. 2008 Dec; 19(12):1281-3.
-
Levine E, Rosero SZ, Budzikowski AS, Moss AJ, Zareba W, Daubert JP. Congenital long QT syndrome: considerations for primary care physicians. Cleve Clin J Med. 2008 Aug; 75(8):591-600.
-
Wu G, Ai T, Kim JJ, Mohapatra B, Xi Y, Li Z, Abbasi S, Purevjav E, Samani K, Ackerman MJ, Qi M, Moss AJ, Shimizu W, Towbin JA, Cheng J, Vatta M. alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption. Circ Arrhythm Electrophysiol. 2008 Aug; 1(3):193-201.
-
Moss AJ, Goldenberg I. Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome. Circ Arrhythm Electrophysiol. 2008 Aug; 1(3):213-26; discussion 226.
-
Moss AJ, Zareba W, Schwarz KQ, Rosero S, McNitt S, Robinson JL. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol. 2008 Dec; 19(12):1289-93.
-
Thottathil P, Acharya J, Moss AJ, Jons C, McNitt S, Goldenberg I, Zareba W, Kaufman E, Qi M, Robinson JL. Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists. Am J Cardiol. 2008 Oct 1; 102(7):871-4.
-
Moss AJ. Do "narrow and tall" QRS complexes "stand tall" and have arrhythmogenic implications? Heart Rhythm. 2008 Sep; 5(9):1346.
-
Liu JF, Goldenberg I, Moss AJ, Shimizu W, Wilde AA, Hofman N, McNitt S, Zareba W, Miyamato Y, Robinson JL, Andrews ML. Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations. Ann Noninvasive Electrocardiol. 2008 Jul; 13(3):234-41.
-
Goldenberg I, Moss AJ, Ryan D, Pietrasik G, Zareba W, McNitt S, Eberly SW. Cumulative burden of atherosclerotic risk genotypes and the age at onset of a first myocardial infarction: a case-only carriership approach. Ann Noninvasive Electrocardiol. 2008 Jul; 13(3):287-94.
-
Goldenberg I, Moss AJ. Long QT syndrome. J Am Coll Cardiol. 2008 Jun 17; 51(24):2291-300.
-
A statement on ethics from the HEART Group. J Interv Cardiol. 2008 Jun; 21(3):279-81.
-
Moss AJ. The long and short of a constipation-reducing medication. N Engl J Med. 2008 May 29; 358(22):2402-3.
-
A Statement on Ethics From the HEART Group. Circ Res. 2008 May 9; 102(9):e104-5.
-
A statement on ethics from the HEART Group. Prog Cardiovasc Dis. 2008 May-Jun; 50(6):475-7.
-
A statement on ethics from the HEART group. Catheter Cardiovasc Interv. 2008 May 1; 71(6):859-61.
-
A statement on ethics from the HEART Group. Am J Cardiol. 2008 May 1; 101(9):1345-6.
-
Ector H, Lancellotti P, Roberts WC, Wenger NK, Moss AJ, Smith ER, Borer JS, Eagle KA, Freedman J, Krum H, Lang C, Remme WJ, Piper HM, White CJ, Loscalzo J, Marbán E, Sobel BE, Roberts R, Rahimtoola SH, Camm AJ, Van de Werf F, Swedberg K, Timmis AD, Stone KS, Zipes DP, Iosselani DG, Taylor AJ, Rosen MR, Grines CL, DeMaria AN, Narula J, King SB, Wagner GS, Saksena S, Pearlman AS, Bodnar E, Emery RW, Cohn LH, van der Wall EE, Abdulla RI, Lesch M, Alfonso F, Ekroth R. A statement on ethics from the HEART Group. JACC Cardiovasc Imaging. 2008 May; 1(3):410-2.
-
A statement on ethics from the HEART Group. J Thorac Cardiovasc Surg. 2008 May; 135(5):976-8.
-
Goldenberg I, Moss AJ. Implantable device therapy. Prog Cardiovasc Dis. 2008 May-Jun; 50(6):449-74.
-
A statement on ethics from the HEART Group. Can J Cardiol. 2008 May; 24(5):361-2.
-
A statement on ethics from the HEART Group. Europace. 2008 May; 10(5):643-5.
-
Goldenberg I, Moss AJ, Bradley J, Polonsky S, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long-QT syndrome after age 40. Circulation. 2008 Apr 29; 117(17):2192-201.
-
Goldenberg I, Moss AJ, Peterson DR, McNitt S, Zareba W, Andrews ML, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Napolitano C, Priori SG, Qi M, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome. Circulation. 2008 Apr 29; 117(17):2184-91.
-
Moss AJ. Life versus death. Circulation. 2008 Apr 15; 117(15):1912-3.
-
Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008 Apr 8; 51(14):1357-65.
-
Kaufman ES, McNitt S, Moss AJ, Zareba W, Robinson JL, Hall WJ, Ackerman MJ, Benhorin J, Locati ET, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Risk of death in the long QT syndrome when a sibling has died. Heart Rhythm. 2008 Jun; 5(6):831-6.
-
Dhar R, Alsheikh-Ali AA, Estes NA, Moss AJ, Zareba W, Daubert JP, Greenberg H, Case RB, Kent DM. Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). Heart Rhythm. 2008 Jun; 5(6):807-13.
-
Moss AJ. What is the real world for analyzing outcomes and costs of ICD therapy? Heart Rhythm. 2008 May; 5(5):654-5.
-
Anthony R, Daubert JP, Zareba W, Andrews ML, McNitt S, Levine E, Huang DT, Hall WJ, Moss AJ. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2008 Feb; 31(2):144-50.
-
Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2008 Jan 22; 51(3):288-96.
-
Gong Q, Zhang L, Moss AJ, Vincent GM, Ackerman MJ, Robinson JC, Jones MA, Tester DJ, Zhou Z. A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome. J Mol Cell Cardiol. 2008 Mar; 44(3):502-9.
-
Mieszczanska H, Pietrasik G, Piotrowicz K, McNitt S, Moss AJ, Zareba W. Gender-related differences in electrocardiographic parameters and their association with cardiac events in patients after myocardial infarction. Am J Cardiol. 2008 Jan 1; 101(1):20-4.
-
Moss AJ. Dynamic electromechanical remodeling of the left ventricle. Ann Noninvasive Electrocardiol. 2008 Jan; 13(1):1-2.
-
Couderc JP, McNitt S, Hyrien O, Vaglio M, Xia X, Polonsky S, Moss AJ, Zareba W. Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin. Drug Saf. 2008; 31(3):249-60.
-
Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients. Arterioscler Thromb Vasc Biol. 2008 Mar; 28(3):548-54.
-
Lehnart SE, Ackerman MJ, Benson DW, Brugada R, Clancy CE, Donahue JK, George AL, Grant AO, Groft SC, January CT, Lathrop DA, Lederer WJ, Makielski JC, Mohler PJ, Moss A, Nerbonne JM, Olson TM, Przywara DA, Towbin JA, Wang LH, Marks AR. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation. 2007 Nov 13; 116(20):2325-45.
-
Crotti L, Spazzolini C, Schwartz PJ, Shimizu W, Denjoy I, Schulze-Bahr E, Zaklyazminskaya EV, Swan H, Ackerman MJ, Moss AJ, Wilde AA, Horie M, Brink PA, Insolia R, De Ferrari GM, Crimi G. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification. Circulation. 2007 Nov 20; 116(21):2366-75.
-
Moss AJ. What duration of the QTc interval should disqualify athletes from competitive sports? Eur Heart J. 2007 Dec; 28(23):2825-6.
-
Couderc JP, Vaglio M, Xia X, McNitt S, Wicker P, Sarapa N, Moss AJ, Zareba W. Impaired T-amplitude adaptation to heart rate characterizes I(Kr) inhibition in the congenital and acquired forms of the long QT syndrome. J Cardiovasc Electrophysiol. 2007 Dec; 18(12):1299-305.
-
Goldenberg I, Moss AJ, Block R, Ryan D, Corsetti JP, McNitt S, Eberly SW, Zareba W. Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers. Ann Noninvasive Electrocardiol. 2007 Oct; 12(4):364-74.
-
Goldenberg I, Moss AJ. Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac disease. Heart Fail Clin. 2007 Oct; 3(4):519-28.
-
Vaglio M, Couderc JP, McNitt S, Xia X, Moss AJ, Zareba W. A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology. Heart Rhythm. 2008 Jan; 5(1):11-8.
-
Couderc JP, Zareba W, McNitt S, Maison-Blanche P, Moss AJ. Repolarization variability in the risk stratification of MADIT II patients. Europace. 2007 Sep; 9(9):717-23.
-
Sesselberg HW, Moss AJ, McNitt S, Zareba W, Daubert JP, Andrews ML, Hall WJ, McClinitic B, Huang DT. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. Heart Rhythm. 2007 Nov; 4(11):1395-402.
-
Pietrasik G, Goldenberg I, Zdzienicka J, Moss AJ, Zareba W. Prognostic significance of fragmented QRS complex for predicting the risk of recurrent cardiac events in patients with Q-wave myocardial infarction. Am J Cardiol. 2007 Aug 15; 100(4):583-6.
-
Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. J Cardiovasc Electrophysiol. 2007 Aug; 18(8):833-8.
-
Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, Moss AJ, Dick AW. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Med Care. 2007 May; 45(5):377-85.
-
Moss AJ, Shimizu W, Wilde AA, Towbin JA, Zareba W, Robinson JL, Qi M, Vincent GM, Ackerman MJ, Kaufman ES, Hofman N, Seth R, Kamakura S, Miyamoto Y, Goldenberg I, Andrews ML, McNitt S. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation. 2007 May 15; 115(19):2481-9.
-
Baris Kaya E, Abali G, Aytemir K, Köse S, Kocabas U, Tokgözoglu L, Kabakçi G, Amasyali B, Ozkutlu H, Nazli N, Oto A. Preliminary observations on the effect of amitriptyline treatment in preventing syncope recurrence in patients with vasovagel syncope. Ann Noninvasive Electrocardiol. 2007 Apr; 12(2):153-7.
-
Dubner SJ, Moss AJ, Schapachnik ES, Levine PA, Perez Riera AR, Camm J, Zareba W. Web-based virtual cardiac symposia: a new approach for worldwide professional medical education. Ann Noninvasive Electrocardiol. 2007 Apr; 12(2):165-70.
-
Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J. 2007 Apr; 153(4 Suppl):53-8.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2007 Apr 3; 49(13):1427-33.
-
Seth R, Moss AJ, McNitt S, Zareba W, Andrews ML, Qi M, Robinson JL, Goldenberg I, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome and pregnancy. J Am Coll Cardiol. 2007 Mar 13; 49(10):1092-8.
-
Morray B, Goldenberg I, Moss AJ, Zareba W, Ryan D, McNitt S, Eberly SW, Glazko G, Mathew J. Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction. Am J Cardiol. 2007 Apr 15; 99(8):1100-5.
-
Corsetti JP, Ryan D, Moss AJ, Rainwater DL, Zareba W, Sparks CE. Glycoprotein Ibalpha polymorphism T145M, elevated lipoprotein-associated phospholipase A2, and hypertriglyceridemia predict risk for recurrent coronary events in diabetic postinfarction patients. Diabetes. 2007 May; 56(5):1429-35.
-
Piotrowicz K, Noyes K, Lyness JM, McNitt S, Andrews ML, Dick A, Hall WJ, Moss AJ, Zareba W. Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II. Eur Heart J. 2007 Mar; 28(5):601-7.
-
Pietrasik G, Goldenberg I, McNitt S, Moss AJ, Zareba W. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients. J Cardiovasc Electrophysiol. 2007 Feb; 18(2):181-4.
-
Goldenberg I, Moss AJ. Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac disease. Clin Geriatr Med. 2007 Feb; 23(1):205-19.
-
Corsetti JP, Ryan D, Moss AJ, Zareba W, Sparks CE. NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients. Atherosclerosis. 2008 Jan; 196(1):461-8.
-
Gomez JF, Zareba W, Moss AJ, McNitt S, Hall WJ. Prognostic value of location and type of myocardial infarction in the setting of advanced left ventricular dysfunction. Am J Cardiol. 2007 Mar 1; 99(5):642-6.
-
Chonchol M, Goldenberg I, Moss AJ, McNitt S, Cheung AK. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. Am J Nephrol. 2007; 27(1):7-14.
-
Sauer AJ, Moss AJ, McNitt S, Peterson DR, Zareba W, Robinson JL, Qi M, Goldenberg I, Hobbs JB, Ackerman MJ, Benhorin J, Hall WJ, Kaufman ES, Locati EH, Napolitano C, Priori SG, Schwartz PJ, Towbin JA, Vincent GM, Zhang L. Long QT syndrome in adults. J Am Coll Cardiol. 2007 Jan 23; 49(3):329-37.
-
Moss AJ. Introductory Note to Alfred Nobel's Will. Ann Noninvasive Electrocardiol. 2007 Jan; 12(1):79-80.
-
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. [Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Executive summary]. Rev Esp Cardiol. 2006 Dec; 59(12):1328.
-
Piotrowicz K, Zareba W, McNitt S, Moss AJ. Repolarization duration in patients with conduction disturbances after myocardial infarction. Am J Cardiol. 2007 Jan 15; 99(2):163-8.
-
Moss AJ. Octopus pot: what does that have to do with adrenergic-related cardiac electro-mechanical dysfunction? J Cardiovasc Electrophysiol. 2006 Dec; 17(12):1348-9.
-
Tan HL, Bardai A, Shimizu W, Moss AJ, Schulze-Bahr E, Noda T, Wilde AA. Genotype-specific onset of arrhythmias in congenital long-QT syndrome: possible therapy implications. Circulation. 2006 Nov 14; 114(20):2096-103.
-
Vorobiof G, Goldenberg I, Moss AJ, Zareba W, McNitt S. Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II). Am J Cardiol. 2006 Nov 15; 98(10):1383-6.
-
Moss AJ. History of Wolff-Parkinson-White syndrome: introductory note to a classic article by Louis Wolff, MD, John Parkinson, MD, and Paul D White, MD. Ann Noninvasive Electrocardiol. 2006 Oct; 11(4):338-9.
-
Hobbs JB, Peterson DR, Moss AJ, McNitt S, Zareba W, Goldenberg I, Qi M, Robinson JL, Sauer AJ, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Towbin JA, Vincent GM, Zhang L. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA. 2006 Sep 13; 296(10):1249-54.
-
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006 Sep 5; 48(5):e247-346.
-
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J. 2006 Sep; 27(17):2099-140.
-
Goldenberg I, Moss AJ, Ryan D, McNitt S, Eberly SW, Zareba W. Polymorphism in the angiotensinogen gene, hypertension, and ethnic differences in the risk of recurrent coronary events. Hypertension. 2006 Oct; 48(4):693-9.
-
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace. 2006 Sep; 8(9):746-837.
-
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006 Sep 5; 114(10):e385-484.
-
Goldenberg I, Moss AJ, Zareba W, McNitt S, Robinson JL, Qi M, Towbin JA, Ackerman MJ, Murphy L. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol. 2006 Nov; 17(11):1161-8.
-
Couderc JP, McNitt S, Xia J, Zareba W, Moss AJ. Repolarization morphology in adult LQT2 carriers with borderline prolonged QTc interval. Heart Rhythm. 2006 Dec; 3(12):1460-6.
-
Goldenberg I, Mathew J, Moss AJ, McNitt S, Peterson DR, Zareba W, Benhorin J, Zhang L, Vincent GM, Andrews ML, Robinson JL, Morray B. Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J Am Coll Cardiol. 2006 Sep 5; 48(5):1047-52.
-
Moss AJ. Atrial electrical activity and atrial fibrillation. Ann Noninvasive Electrocardiol. 2006 Jul; 11(3):201-2.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ, Greenberg H, Case RB. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol. 2006 Aug 15; 98(4):485-90.
-
Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation. 2006 Jun 20; 113(24):2810-7.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Daubert JP, Hall WJ, Andrews ML. Cigarette smoking and the risk of supraventricular and ventricular tachyarrhythmias in high-risk cardiac patients with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol. 2006 Sep; 17(9):931-6.
-
Corsetti JP, Rainwater DL, Moss AJ, Zareba W, Sparks CE. High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients. Clin Chem. 2006 Jul; 52(7):1331-8.
-
Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006 Jun 6; 47(11):2310-8.
-
Karp JM, Moss AJ. Dental treatment of patients with long QT syndrome. J Am Dent Assoc. 2006 May; 137(5):630-7.
-
Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML, Wilber DJ, Klein HU. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006 May 2; 47(9):1811-7.
-
Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006 Apr 11; 113(14):1807-16.
-
Goldenberg I, Moss AJ, Zareba W. QT interval: how to measure it and what is "normal". J Cardiovasc Electrophysiol. 2006 Mar; 17(3):333-6.
-
Zareba W, Steinberg JS, McNitt S, Daubert JP, Piotrowicz K, Moss AJ. Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm. 2006 Jun; 3(6):631-7.
-
Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol. 2006 Feb 21; 47(4):769-73.
-
Moss AJ. QTc prolongation and sudden cardiac death: the association is in the detail. J Am Coll Cardiol. 2006 Jan 17; 47(2):368-9.
-
Moss AJ. Drug-induced QT prolongation: an update. Ann Noninvasive Electrocardiol. 2006 Jan; 11(1):1-2.
-
Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2006 Jan 3; 47(1):98-107.
-
Zareba W, Moss AJ, Jackson Hall W, Wilber DJ, Ruskin JN, McNitt S, Brown M, Wang H. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol. 2005 Dec; 16(12):1265-70.
-
Corsetti JP, Zareba W, Moss AJ, Rainwater DL, Sparks CE. Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation. Atherosclerosis. 2006 Jul; 187(1):191-7.
-
Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol. 2005 Nov 1; 46(9):1712-20.
-
Moss AJ, Brown MW, Cannom DS, Daubert JP, Estes M, Foster E, Greenberg HM, Hall WJ, Higgins SL, Klein H, Pfeffer M, Wilber D, Zareba W. Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):34-43.
-
Moss AJ, Windle JR, Hall WJ, Zareba W, Robinson JL, McNitt S, Severski P, Rosero S, Daubert JP, Qi M, Cieciorka M, Manalan AS. Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):59-66.
-
Badilini F, Erdem T, Zareba W, Moss AJ. ECGScan: a method for conversion of paper electrocardiographic printouts to digital electrocardiographic files. J Electrocardiol. 2005 Oct; 38(4):310-8.
-
Goldenberg I, Moss AJ, Maron BJ, Dick AW, Zareba W. Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4 Suppl):67-83.
-
Berenbom LD, Weiford BC, Vacek JL, Emert MP, Hall WJ, Andrews ML, McNitt S, Zareba W, Moss AJ. Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II. Ann Noninvasive Electrocardiol. 2005 Oct; 10(4):429-35.
-
Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W, Hall WJ, Andrews M, McNitt S, Daubert JP. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol. 2005 Sep 1; 96(5):691-5.
-
Goldenberg I, Moss AJ, Zareba W. Sudden cardiac death without structural heart disease: update on the long QT and Brugada syndromes. Curr Cardiol Rep. 2005 Sep; 7(5):349-56.
-
Moss AJ. What resides in T-wave residuum? J Cardiovasc Electrophysiol. 2005 Sep; 16(9):952-3.
-
Moss AJ, Kass RS. Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest. 2005 Aug; 115(8):2018-24.
-
Wittenberg SM, Cook JR, Hall WJ, McNitt S, Zareba W, Moss AJ. Comparison of efficacy of implanted cardioverter-defibrillator in patients with versus without diabetes mellitus. Am J Cardiol. 2005 Aug 1; 96(3):417-9.
-
Moss AJ, Ryan D, Oakes D, Goldstein RE, Greenberg H, Bodenheimer MM, Brown MW, Case RB, Dwyer EM, Eberly SW, Francis CW, Gillespie JA, Krone RJ, Lichstein E, MacCluer JW, Marcus FI, McCarthy J, Sparks CE, Zareba W. Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. Am J Cardiol. 2005 Jul 15; 96(2):177-82.
-
Moss AJ. Heart failure: a central factor in progressive mechanical and electrical cardiac dysfunction. Ann Noninvasive Electrocardiol. 2005 Jul; 10(3):279-80.
-
Zareba W, Piotrowicz K, McNitt S, Moss AJ. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Am J Cardiol. 2005 Jun 15; 95(12):1487-91.
-
Al-Khatib SM, Sanders GD, Mark DB, Lee KL, Bardy GH, Bigger JT, Buxton AE, Connolly S, Kadish A, Moss A, Feldman AM, Ellenbogen KA, Singh S, Califf RM. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J. 2005 Jun; 149(6):1020-34.
-
Corsetti JP, Zareba W, Moss AJ, Sparks CE. Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients. Atherosclerosis. 2005 Dec; 183(2):293-300.
-
Moss AJ. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation. 2005 May 17; 111(19):2537-49; discussion 2537-49.
-
Greenland P, Lloyd-Jones DM, Moss AJ. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005 Apr 14; 352(15):1603-5; author reply 1603-5.
-
Steinberg JS, Fischer A, Wang P, Schuger C, Daubert J, McNitt S, Andrews M, Brown M, Hall WJ, Zareba W, Moss AJ. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II. J Cardiovasc Electrophysiol. 2005 Apr; 16(4):359-65.
-
Moss AJ, Schwartz PJ. 25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. Circulation. 2005 Mar 8; 111(9):1199-201.
-
Stern S, Moss AJ. Introduction to articles honoring Bruce Del Mar and his contributions to noninvasive electrocardiology. Ann Noninvasive Electrocardiol. 2005 Jan; 10(1):86-7.
-
Kaya D, Karaca S, Barutcu I, Esen AM, Kulac M, Esen O. Heart rate variability in patients with essential hyperhidrosis: dynamic influence of sympathetic and parasympathetic maneuvers. Ann Noninvasive Electrocardiol. 2005 Jan; 10(1):1-6.
-
Couderc JP, Xiaojuan X, Zareba W, Moss AJ. Assessment of the stability of the individual-based correction of QT interval for heart rate. Ann Noninvasive Electrocardiol. 2005 Jan; 10(1):25-34.
-
Moss AJ, Dubner SJ, Schapachnik E, Perez Riera AR. Virtual cardiac symposia: Worldwide, Internet-based, educational forums for cardiologists. Am J Cardiol. 2004 Dec 15; 94(12):1588-9.
-
Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation. 2004 Dec 21; 110(25):3760-5.
-
Corsetti JP, Zareba W, Moss AJ, Sparks CE. Apolipoprotein B determines risk for recurrent coronary events in postinfarction patients with metabolic syndrome. Atherosclerosis. 2004 Dec; 177(2):367-73.
-
Moss AJ. The heart does not have Alzheimer's disease: electrical and mechanical cardiac memory after ventricular pacing. J Am Coll Cardiol. 2004 Nov 2; 44(9):1889-90.
-
Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol. 2004 Oct 6; 44(7):1481-7.
-
Moss AJ. Introductory note to a classic article on the auriculo-ventricular bundle by Keith and Flack. Ann Noninvasive Electrocardiol. 2004 Oct; 9(4):399.
-
Moss AJ. Noninvasive electrocardiology has come of age. Ann Noninvasive Electrocardiol. 2004 Oct; 9(4):307-8.
-
Moss AJ. Quantifying T wave morphology in the digital era. Heart Rhythm. 2004 Sep; 1(3):293-4.
-
Moss AJ, Vyas A, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, McNitt SA, Andrews ML. Temporal aspects of improved survival with the implanted defibrillator (MADIT-II). Am J Cardiol. 2004 Aug 1; 94(3):312-5.
-
Moss AJ. Exercise testing. Ann Noninvasive Electrocardiol. 2004 Jul; 9(3):199-200.
-
Berkowitsch A, Zareba W, Neumann T, Erdogan A, Nitt SM, Moss AJ, Pitschner HF. Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording. Ann Noninvasive Electrocardiol. 2004 Jul; 9(3):270-9.
-
Moss AJ. Introductory note to a classic article by Robert A. Bruce. Ann Noninvasive Electrocardiol. 2004 Jul; 9(3):290.
-
Moss AJ. Comments on ethical issues with implantable defibrillators by F. James Brennan. Pacing Clin Electrophysiol. 2004 Jul; 27(7):900.
-
Kaba NK, Francis CW, Moss AJ, Zareba W, Oakes D, Knox KL, Fernández ID, Rainwater DL. Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction. J Thromb Haemost. 2004 May; 2(5):718-25.
-
Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol. 2004 Apr 21; 43(8):1459-65.
-
Moss AJ. Modulating effects of sex hormones on cardiac function. Ann Noninvasive Electrocardiol. 2004 Apr; 9(2):99-100.
-
Moss AJ. Introductory note to a classic article by Augustus D. Waller. Ann Noninvasive Electrocardiol. 2004 Apr; 9(2):187-8.
-
Schwartz PJ, Priori SG, Cerrone M, Spazzolini C, Odero A, Napolitano C, Bloise R, De Ferrari GM, Klersy C, Moss AJ, Zareba W, Robinson JL, Hall WJ, Brink PA, Toivonen L, Epstein AE, Li C, Hu D. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome. Circulation. 2004 Apr 20; 109(15):1826-33.
-
Wilber DJ, Zareba W, Hall WJ, Brown MW, Lin AC, Andrews ML, Burke M, Moss AJ. Time dependence of mortality risk and defibrillator benefit after myocardial infarction. Circulation. 2004 Mar 9; 109(9):1082-4.
-
Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ, Lichstein E. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med. 2004 Feb 23; 164(4):440-6.
-
Moss AJ. A renaissance in electrocardiography. Ann Noninvasive Electrocardiol. 2004 Jan; 9(1):1-2.
-
Moss AJ. Introductory note to a classic article by Dr. Fred M. Smith. Ann Noninvasive Electrocardiol. 2004 Jan; 9(1):78-9.
-
Feldman AM, Klein H, Tchou P, Murali S, Hall WJ, Mancini D, Boehmer J, Harvey M, Heilman MS, Szymkiewicz SJ, Moss AJ. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD. Pacing Clin Electrophysiol. 2004 Jan; 27(1):4-9.
-
Sarapa N, Morganroth J, Couderc JP, Francom SF, Darpo B, Fleishaker JC, McEnroe JD, Chen WT, Zareba W, Moss AJ. Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods. Ann Noninvasive Electrocardiol. 2004 Jan; 9(1):48-57.
-
Corsetti JP, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rainwater DL, Sparks CE. Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients. Atherosclerosis. 2003 Dec; 171(2):351-8.
-
Moss AJ. MADIT-II: substudies and their implications. Card Electrophysiol Rev. 2003 Dec; 7(4):430-3.
-
Zareba W, Moss AJ, Sheu G, Kaufman ES, Priori S, Vincent GM, Towbin JA, Benhorin J, Schwartz PJ, Napolitano C, Hall WJ, Keating MT, Qi M, Robinson JL, Andrews ML. Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome. J Cardiovasc Electrophysiol. 2003 Nov; 14(11):1149-53.
-
Moss AJ. Introductory note to a translated classic article of L. S. Fridericia. Ann Noninvasive Electrocardiol. 2003 Oct; 8(4):341-2.
-
Moss AJ. Ventricular repolarization. Ann Noninvasive Electrocardiol. 2003 Oct; 8(4):267-8.
-
Kass RS, Moss AJ. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest. 2003 Sep; 112(6):810-5.
-
Moss AJ. MADIT-I and MADIT-II. J Cardiovasc Electrophysiol. 2003 Sep; 14(9 Suppl):S96-8.
-
Moss AJ. Dead is dead, but can we identify patients at increased risk for sudden cardiac death? J Am Coll Cardiol. 2003 Aug 20; 42(4):659-60.
-
Zareba W, Moss AJ, Locati EH, Lehmann MH, Peterson DR, Hall WJ, Schwartz PJ, Vincent GM, Priori SG, Benhorin J, Towbin JA, Robinson JL, Andrews ML, Napolitano C, Timothy K, Zhang L, Medina A. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol. 2003 Jul 2; 42(1):103-9.
-
Moss AJ. Correcting misconceptions. Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):177-8.
-
Ning L, Moss AJ, Zareba W, Robinson J, Rosero S, Ryan D, Qi M. Novel compound heterozygous mutations in the KCNQ1 gene associated with autosomal recessive long QT syndrome (Jervell and Lange-Nielsen syndrome). Ann Noninvasive Electrocardiol. 2003 Jul; 8(3):246-50.
-
Marcus F, Towbin JA, Zareba W, Moss A, Calkins H, Brown M, Gear K. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol. Circulation. 2003 Jun 17; 107(23):2975-8.
-
Filla A, Moss AJ. Idebenone for treatment of Friedreich's ataxia? Neurology. 2003 May 27; 60(10):1569-70.
-
Harb TS, Zareba W, Moss AJ, Ridker PM, Rifai N, Marder VJ, Miller-Watelet L. Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients. Am J Cardiol. 2003 May 1; 91(9):1120-3.
-
Sesselberg HW, Moss AJ, Steinberg J, Carroll E, Zareba W, Daubert J, Huang DT. Factors associated with ventricular inducibility in the MADIT-II study population. Am J Cardiol. 2003 Apr 15; 91(8):1002-4, A7.
-
Moss AJ. Long QT Syndrome. JAMA. 2003 Apr 23-30; 289(16):2041-4.
-
Moss AJ. Introductory note to a classic article by Francis Galton. Ann Noninvasive Electrocardiol. 2003 Apr; 8(2):170.
-
Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol. 2003 Apr; 14(4):337-41.
-
Moss AJ. It is time to establish a subspecialty in noninvasive electrocardiology. Ann Noninvasive Electrocardiol. 2003 Apr; 8(2):99-100.
-
Fadl YY, Zareba W, Moss AJ, Marder VJ, Sparks CS, Miller Watelet LF, Carroll ER. History of hypertension and enhanced thrombogenic activity in postinfarction patients. Hypertension. 2003 Apr; 41(4):943-9.
-
Moss AJ. MADIT-II and its implications. Eur Heart J. 2003 Jan; 24(1):16-8.
-
Moss AJ. Atrial fibrillation. Ann Noninvasive Electrocardiol. 2003 Jan; 8(1):1-2.
-
Zareba W, Moss AJ. Noninvasive risk stratification in postinfarction patients with severe left ventricular dysfunction and methodology of the MADIT II noninvasive electrocardiology substudy. J Electrocardiol. 2003; 36 Suppl:101-8.
-
Ning L, Moss A, Zareba W, Robinson J, Rosero S, Ryan D, Qi M. Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome. Genet Test. 2003; 7(3):249-53.
-
Moss AJ. History of atrial fibrillation. Ann Noninvasive Electrocardiol. 2003 Jan; 8(1):90-1.
-
Couderc JP, Zareba W, Moss AJ, Sarapa N, Morganroth J, Darpo B. Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters. J Electrocardiol. 2003; 36 Suppl:115-20.
-
Moss AJ, Daubert J, Zareba W. MADIT-II: clinical implications. Card Electrophysiol Rev. 2002 Dec; 6(4):463-5.
-
Moss AJ. The ECG: predicting cardiac events after myocardial infarction with a brief historical perspective. Ann Noninvasive Electrocardiol. 2002 Oct; 7(4):279-80.
-
Perkiomaki JS, Zareba W, Badilini F, Moss AJ. Influence of atropine on fractal and complexity measures of heart rate variability. Ann Noninvasive Electrocardiol. 2002 Oct; 7(4):326-31.
-
Moss AJ. T-wave patterns associated with the hereditary long QT syndrome. Card Electrophysiol Rev. 2002 Sep; 6(3):311-5.
-
Perkiomaki JS, Zareba W, Greenberg HM, Moss AJ. Usefulness of standard electrocardiographic parameters for predicting cardiac events after acute myocardial infarction during modern treatment era. Am J Cardiol. 2002 Aug 1; 90(3):205-9.
-
Ott P, Marcus FI, Moss AJ. Images in cardiovascular medicine. Ventricular fibrillation during swimming in a patient with long-QT syndrome. Circulation. 2002 Jul 23; 106(4):521-2.
-
Perkiömäki JS, Zareba W, Nomura A, Andrews M, Kaufman ES, Moss AJ. Repolarization dynamics in patients with long QT syndrome. J Cardiovasc Electrophysiol. 2002 Jul; 13(7):651-6.
-
Moss AJ, Goldstein RE, Greenberg H, Dwyer EM, Bigger JT, Case RB. The multicenter research group. Ann Noninvasive Electrocardiol. 2002 Jul; 7(3):271-7.
-
Moss AJ. MADIT-II and implications for noninvasive electrophysiologic testing. Ann Noninvasive Electrocardiol. 2002 Jul; 7(3):179-80.
-
Moss AJ, Longstreth WT. In-flight neurologic emergencies. Neurology. 2002 Jun 25; 58(12):1717.
-
Wang Z, Li H, Moss AJ, Robinson J, Zareba W, Knilans T, Bowles NE, Towbin JA. Compound heterozygous mutations in KvLQT1 cause Jervell and Lange-Nielsen syndrome. Mol Genet Metab. 2002 Apr; 75(4):308-16.
-
Moss AJ. History of preexcitation: "A Case in Which the Vagus Influenced the Form of the Ventricular Complex of the Electrocardiogram". Ann Noninvasive Electrocardiol. 2002 Apr; 7(2):152.
-
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21; 346(12):877-83.
-
Moss AJ, Zareba W, Kaufman ES, Gartman E, Peterson DR, Benhorin J, Towbin JA, Keating MT, Priori SG, Schwartz PJ, Vincent GM, Robinson JL, Andrews ML, Feng C, Hall WJ, Medina A, Zhang L, Wang Z. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation. 2002 Feb 19; 105(7):794-9.
-
Harb TS, Zareba W, Moss AJ, Ridker PM, Marder VJ, Rifai N, Miller Watelet LF, Arora R, Brown MW, Case RB, Dwyer EM, Gillespie JA, Goldstein RE, Greenberg H, Hochman J, Krone RJ, Liang CS, Lichstein E, Little W, Marcus FI, Oakes D, Sparks CE, VanVoorhees L. Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol. 2002 Jan 15; 89(2):216-21.
-
Benhorin J, Moss AJ, Bak M, Zareba W, Kaufman ES, Kerem B, Towbin JA, Priori S, Kass RS, Attali B, Brown AM, Ficker E. Variable expression of long QT syndrome among gene carriers from families with five different HERG mutations. Ann Noninvasive Electrocardiol. 2002 Jan; 7(1):40-6.
-
Hajj-Ali R, Zareba W, Ezzeddine R, Moss AJ. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am J Cardiol. 2001 Dec 1; 88(11):1221-4.
-
Zareba W, Sattari MN, Rosero S, Couderc JP, Moss AJ. Altered atrial, atrioventricular, and ventricular conduction in patients with the long QT syndrome caused by the DeltaKPQ SCN5A sodium channel gene mutation. Am J Cardiol. 2001 Dec 1; 88(11):1311-4.
-
Moss AJ, Zareba W, Benhorin J, Couderc JP, Kennedy H, Locati-Heilbron E, Maison-Blanche P. ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization. Ann Noninvasive Electrocardiol. 2001 Oct; 6(4):333-41.
-
Perkiömäki JS, Zareba W, Couderc JP, Moss AJ. Heart rate variability in patients with congenital long QT syndrome. Ann Noninvasive Electrocardiol. 2001 Oct; 6(4):298-304.
-
Zareba W, Pancio G, Moss AJ, Kalaria VG, Marder VJ, Weiss HJ, Watelet LF, Sparks CE. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators. Thromb Haemost. 2001 Sep; 86(3):791-9.
-
Moss AJ, Fadl Y, Zareba W, Cannom DS, Hall WJ. Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. Am J Cardiol. 2001 Sep 1; 88(5):516-20.
-
Kimbrough J, Moss AJ, Zareba W, Robinson JL, Hall WJ, Benhorin J, Locati EH, Medina A, Napolitano C, Priori S, Schwartz PJ, Timothy K, Towbin JA, Vincent GM, Zhang L. Clinical implications for affected parents and siblings of probands with long-QT syndrome. Circulation. 2001 Jul 31; 104(5):557-62.
-
Moss AJ. The electrocardiogram: from Einthoven to molecular genetics. Ann Noninvasive Electrocardiol. 2001 Jul; 6(3):181-2.
-
Vulapalli R, Liang C, Zareba W, Moss AJ. Recurrent coronary events are not increased in postinfarction patients with methylenetetrahydrofolate reductase gene C677T polymorphism. Am J Cardiol. 2001 Jun 1; 87(11):1289-92.
-
Moss AJ. Long QT syndrome: more questions. J Cardiovasc Electrophysiol. 2001 Apr; 12(4):462.
-
Windle JR, Geletka RC, Moss AJ, Zareba W, Atkins DL. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation. Ann Noninvasive Electrocardiol. 2001 Apr; 6(2):153-8.
-
Perkiömäki JS, Zareba W, Kalaria VG, Couderc J, Huikuri HV, Moss AJ. Comparability of nonlinear measures of heart rate variability between long- and short-term electrocardiographic recordings. Am J Cardiol. 2001 Apr 1; 87(7):905-8.
-
Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, Guicheney P, Breithardt G, Keating MT, Towbin JA, Beggs AH, Brink P, Wilde AA, Toivonen L, Zareba W, Robinson JL, Timothy KW, Corfield V, Wattanasirichaigoon D, Corbett C, Haverkamp W, Schulze-Bahr E, Lehmann MH, Schwartz K, Coumel P, Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001 Jan 2; 103(1):89-95.
-
Zareba W, Moss AJ. Long QT syndrome in children. J Electrocardiol. 2001; 34 Suppl:167-71.
-
Moss AJ, Kouwenhoven WB, Jude JR, Knickerbocker GG. Closed-chest cardiac massage. 1960. Ann Noninvasive Electrocardiol. 2001 Jan; 6(1):78-80.
-
Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, Shen J, Splawski I, Priori SG, Compton SJ, Yanowitz F, Benhorin J, Moss AJ, Schwartz PJ, Robinson JL, Wang Q, Zareba W, Keating MT, Towbin JA, Napolitano C, Medina A. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000 Dec 5; 102(23):2849-55.
-
Watelet LF, Moss AJ, Zareba W, Oakes D, Ryan D. Detection of a group of risk factors in coronary disease using a new carriership analysis approach. Am J Cardiol. 2000 Dec 1; 86(11):1253-6, A6.
-
Fisher SD, Zareba W, Moss AJ, Marder VJ, Sparks CE, Hochman J, Liang C, Krone RJ. Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction. Am J Cardiol. 2000 Oct 15; 86(8):813-8.
-
Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation. 2000 Sep 12; 102(11):1258-63.
-
Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000 Sep 5; 102(10):1178-85.
-
Moss AJ. Phenotype (ECG)-genotype considerations in long QT syndrome and Brugada syndrome. J Cardiovasc Electrophysiol. 2000 Sep; 11(9):1055-7.
-
Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J. 2000 Aug; 21(15):1216-31.
-
Haverkamp W, Breithardt G, Camm AJ, Janse MJ, Rosen MR, Antzelevitch C, Escande D, Franz M, Malik M, Moss A, Shah R. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res. 2000 Aug; 47(2):219-33.
-
Kalaria VG, Zareba W, Moss AJ, Pancio G, Marder VJ, Morrissey JH, Weiss HJ, Sparks CE, Greenberg H, Dwyer E, Goldstein R, Watelet LF. Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol. 2000 Jun 15; 85(12):1401-8.
-
Moss AJ. Implantable cardioverter defibrillator therapy: the sickest patients benefit the most. Circulation. 2000 Apr 11; 101(14):1638-40.
-
Ali RH, Zareba W, Moss AJ, Schwartz PJ, Benhorin J, Vincent GM, Locati EH, Priori S, Napolitano C, Towbin JA, Hall WJ, Robinson JL, Andrews ML, Zhang L, Timothy K, Medina A. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol. 2000 Feb 15; 85(4):457-61.
-
Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, Vincent GM, Locati EH, Priori SG, Napolitano C, Medina A, Zhang L, Robinson JL, Timothy K, Towbin JA, Andrews ML. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000 Feb 15; 101(6):616-23.
-
Moss AJ, Daubert JP. Images in clinical medicine. Internal ventricular defibrillation. N Engl J Med. 2000 Feb 10; 342(6):398.
-
Nomura A, Zareba W, Moss AJ. Obesity does not influence electrocardiographic parameters in coronary patients. Am J Cardiol. 2000 Jan 1; 85(1):106-8, A9.
-
Rosero SZ, Zareba W, Moss AJ, Robinson JL, Hajj Ali RH, Locati EH, Benhorin J, Andrews ML. Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group. Am J Cardiol. 1999 Dec 15; 84(12):1406-11.
-
Marder VJ, Zareba W, Horan JT, Moss AJ, Kanouse JJ. Automated latex agglutination and ELISA testing yield equivalent D-dimer results in patients with recent myocardial infarction. THROMBO Research Investigators. Thromb Haemost. 1999 Nov; 82(5):1412-6.
-
Couderc JP, Zareba W, Burattini L, Moss AJ. Beat-to-Beat repolarization variability in LQTS patients with the SCN5A sodium channel gene mutation. Pacing Clin Electrophysiol. 1999 Nov; 22(11):1581-92.
-
Moss AJ, Robinson JL, Gessman L, Gillespie R, Zareba W, Schwartz PJ, Vincent GM, Benhorin J, Heilbron EL, Towbin JA, Priori SG, Napolitano C, Zhang L, Medina A, Andrews ML, Timothy K. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol. 1999 Oct 15; 84(8):876-9.
-
Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J. 1999 Sep; 138(3 Pt 1):577-85.
-
Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Ethnicity and long-term outcome after an acute coronary event. Multicenter Myocardial Ischemia Research Group. Am Heart J. 1999 Sep; 138(3 Pt 1):500-6.
-
Moss AJ, Chaikin P, Garcia JD, Gillen M, Roberts DJ, Morganroth J. A review of the cardiac systemic side-effects of antihistamines: ebastine. Clin Exp Allergy. 1999 Jul; 29 Suppl 3:200-5.
-
Moss AJ, Goldstein RE, Marder VJ, Sparks CE, Oakes D, Greenberg H, Weiss HJ, Zareba W, Brown MW, Liang CS, Lichstein E, Little WC, Gillespie JA, Van Voorhees L, Krone RJ, Bodenheimer MM, Hochman J, Dwyer EM, Arora R, Marcus FI, Watelet LF, Case RB. Thrombogenic factors and recurrent coronary events. Circulation. 1999 May 18; 99(19):2517-22.
-
Chen Q, Zhang D, Gingell RL, Moss AJ, Napolitano C, Priori SG, Schwartz PJ, Kehoe E, Robinson JL, Schulze-Bahr E, Wang Q, Towbin JA. Homozygous deletion in KVLQT1 associated with Jervell and Lange-Nielsen syndrome. Circulation. 1999 Mar 16; 99(10):1344-7.
-
Phibbs B, Marcus F, Marriott HJ, Moss A, Spodick DH. Q-wave versus non-Q wave myocardial infarction: a meaningless distinction. J Am Coll Cardiol. 1999 Feb; 33(2):576-82.
-
Moss AJ. The QT interval and torsade de pointes. Drug Saf. 1999; 21 Suppl 1:5-10; discussion 81-7.
-
Moss AJ, Morganroth J. Cardiac effects of ebastine and other antihistamines in humans. Drug Saf. 1999; 21 Suppl 1:69-80; discussion 81-7.
-
Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998 Oct 1; 339(14):960-5.
-
Locati EH, Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Lehmann MH, Towbin JA, Priori SG, Napolitano C, Robinson JL, Andrews M, Timothy K, Hall WJ. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation. 1998 Jun 9; 97(22):2237-44.
-
Mushlin AI, Hall WJ, Zwanziger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ. The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. Circulation. 1998 Jun 2; 97(21):2129-35.
-
Moss AJ. Management of patients with the hereditary long QT syndrome. J Cardiovasc Electrophysiol. 1998 Jun; 9(6):668-74.
-
Li H, Chen Q, Moss AJ, Robinson J, Goytia V, Perry JC, Vincent GM, Priori SG, Lehmann MH, Denfield SW, Duff D, Kaine S, Shimizu W, Schwartz PJ, Wang Q, Towbin JA. New mutations in the KVLQT1 potassium channel that cause long-QT syndrome. Circulation. 1998 Apr 7; 97(13):1264-9.
-
Nichol G, Hallstrom AP, Kerber R, Moss AJ, Ornato JP, Palmer D, Riegel B, Smith S, Weisfeldt ML. American Heart Association report on the second public access defibrillation conference, April 17-19, 1997. Circulation. 1998 Apr 7; 97(13):1309-14.
-
Rashba EJ, Zareba W, Moss AJ, Hall WJ, Robinson J, Locati EH, Schwartz PJ, Andrews M. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation. 1998 Feb 10; 97(5):451-6.
-
Zareba W, Moss AJ, Konecki J. TU wave area-derived measures of repolarization dispersion in the long QT syndrome. J Electrocardiol. 1998; 30 Suppl:191-5.
-
Burattini L, Zareba W, Rashba EJ, Couderc JP, Konecki J, Moss AJ. ECG features of microvolt T-wave alternans in coronary artery disease and long QT syndrome patients. J Electrocardiol. 1998; 31 Suppl:114-20.
-
Couderc JP, Zareba W, Burattini L, Konecki JA, Moss AJ. Beat-to-beat repolarization variability in amplitude and duration in LQTS patients with the SCN5A sodium channel gene mutation. J Electrocardiol. 1998; 31 Suppl:134.
-
Moss AJ. The long QT syndrome revisited: current understanding and implications for treatment. Pacing Clin Electrophysiol. 1997 Dec; 20(12 Pt 1):2879-81.
-
Zareba W, Moss AJ, Rosero SZ, Hajj-Ali R, Konecki J, Andrews M. Electrocardiographic findings in patients with diphenhydramine overdose. Am J Cardiol. 1997 Nov 1; 80(9):1168-73.
-
Moss AJ. The absence of ventricular premature beats on a Holter is like a normal sedimentation rate. Eur Heart J. 1997 Nov; 18(11):1690-1.
-
Moss AJ. Background, outcome, and clinical implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT) Am J Cardiol. 1997 Sep 11; 80(5B):28F-32F.
-
Moss AJ. Clinical management of patients with the long QT syndrome: drugs, devices, and gene-specific therapy. Pacing Clin Electrophysiol. 1997 Aug; 20(8 Pt 2):2058-60.
-
Moss AJ. Update on MADIT: the Multicenter Automatic Defibrillator Implantation Trial. The long QT interval syndrome. Am J Cardiol. 1997 Mar 20; 79(6A):16-9.
-
Narins CR, Zareba W, Moss AJ, Goldstein RE, Hall WJ. Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol. 1997 Mar 15; 29(4):756-63.
-
Cohn JN, Bristow MR, Chien KR, Colucci WS, Frazier OH, Leinwand LA, Lorell BH, Moss AJ, Sonnenblick EH, Walsh RA, Mockrin SC, Reinlib L. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation. 1997 Feb 18; 95(4):766-70.
-
Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Differential effects of beta-blockers in patients after recovery from myocardial infarction and after recovery from unstable angina. Multicenter Myocardial Ischemia Research Group. Heart Vessels. 1997; Suppl 12:160-1.
-
Lehmann MH, Timothy KW, Frankovich D, Fromm BS, Keating M, Locati EH, Taggart RT, Towbin JA, Moss AJ, Schwartz PJ, Vincent GM. Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. J Am Coll Cardiol. 1997 Jan; 29(1):93-9.
-
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996 Dec 26; 335(26):1933-40.
-
Weisfeldt ML, Kerber RE, McGoldrick RP, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC. Public access to defibrillation. The Automatic Defibrillation Task Force. Am J Emerg Med. 1996 Nov; 14(7):684-92.
-
Weisfeldt ML, Kerber RE, McGoldrick RP, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC. Statement on public access defibrillation. American Heart Association Taskforce on Automatic External Defibrillation. Resuscitation. 1996 Sep; 32(2):125-6.
-
Weisfeldt ML, Kerber RE, McGoldrick RP, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC. American Heart Association Report on the Public Access Defibrillation Conference, December 8-10, 1994. American Heart Association Taskforce on Automatic External Defibrillation. Resuscitation. 1996 Sep; 32(2):127-38.
-
Moss AJ. "Rush-a-homa": is a shorter hospital stay better for the patient? J Am Coll Cardiol. 1996 Aug; 28(2):294-5.
-
Goldstein RE, Andrews M, Hall WJ, Moss AJ. Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol. 1996 Aug; 28(2):326-30.
-
Nakamura Y, Kawai C, Moss AJ, Raubertas RF, Brown MW, Kinoshita M, Sasayama S, Nonogi H, Omae T, Tamaki S, Fujita M, Tanaka N, Hosoda S, Inoue H, Sugimoto T, Iinuma H, Kato K, Tamaki N, Sugiura N. Comparison between Japan and North America in the post-hospital course after recovery from an acute coronary event. Int J Cardiol. 1996 Aug; 55(3):245-54.
-
Moss AJ. Correct the QT interval correctly: QTc should be expressed in the same unit as the QT interval. Pacing Clin Electrophysiol. 1996 Jun; 19(6):881-2.
-
Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1; 93(5):1043-65.
-
Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD, Keating MT. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet. 1996 Jan; 12(1):17-23.
-
Andros E, Detmar-Hanna D, Suteparuk S, Gal J, Gerber JG. The effect of aging on the pharmacokinetics and pharmacodynamics of prazosin. Eur J Clin Pharmacol. 1996; 50(1-2):41-6.
-
Moss AJ. What can be expected for the management of heart failure in the near future? Eur J Clin Pharmacol. 1996; 49 Suppl 1:S41-4.
-
Zareba W, Moss AJ, le Cessie S, Locati EH, Robinson JL, Hall WJ, Andrews ML. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol. 1995 Dec; 26(7):1685-91.
-
Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, Towbin JA, Vincent GM, Lehmann MH. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995 Nov 15; 92(10):2929-34.
-
Weisfeldt ML, Kerber RE, McGoldrick RP, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC. American Heart Association Report on the Public Access Defibrillation Conference December 8-10, 1994. Automatic External Defibrillation Task Force. Circulation. 1995 Nov 1; 92(9):2740-7.
-
Weisfeldt ML, Kerber RE, McGoldrick RP, Moss AJ, Nichol G, Ornato JP, Palmer DG, Riegel B, Smith SC. Public access defibrillation. A statement for healthcare professionals from the American Heart Association Task Force on Automatic External Defibrillation. Circulation. 1995 Nov 1; 92(9):2763.
-
Ouriel K, Moss AJ. Long QT syndrome: an indication for cervicothoracic sympathectomy. Cardiovasc Surg. 1995 Oct; 3(5):475-8.
-
Martin AB, Perry JC, Robinson JL, Zareba W, Moss AJ, Garson A. Calculation of QTc duration and variability in the presence of sinus arrhythmia. Am J Cardiol. 1995 May 1; 75(14):950-2.
-
Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA, Keating MT. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995 Mar 10; 80(5):805-11.
-
Zareba W, Moss AJ. Dispersion of repolarization. Relation to heart rate and repolarization duration. J Electrocardiol. 1995; 28 Suppl:202-6.
-
Lai LP, Deng CL, Moss AJ, Kass RS, Liang CS. Polymorphism of the gene encoding a human minimal potassium ion channel (minK). Gene. 1994 Dec 30; 151(1-2):339-40.
-
Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q-wave and Q-wave myocardial infarction: the limited role of non-invasive testing. The Multicenter Myocardial Ischemia Research Group. Coron Artery Dis. 1994 Dec; 5(12):1009-18.
-
Towbin JA, Li H, Taggart RT, Lehmann MH, Schwartz PJ, Satler CA, Ayyagari R, Robinson JL, Moss A, Hejtmancik JF. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome. Analysis of 23 families. Circulation. 1994 Dec; 90(6):2635-44.
-
Weitkamp LR, Moss AJ, Lewis RA, Hall WJ, MacCluer JW, Schwartz PJ, Locati EH, Tzivoni D, Vincent GM, Robinson JL, et al. Analysis of HLA and disease susceptibility: chromosome 6 genes and sex influence long-QT phenotype. Am J Hum Genet. 1994 Dec; 55(6):1230-41.
-
Krone RJ, Gregory JJ, Freedland KE, Kleiger RE, Wackers FJ, Bodenheimer MM, Benhorin J, Schwartz RG, Parker JO, Van Voorhees L, et al. Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: implications for management of stable coronary heart disease. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol. 1994 Nov 1; 24(5):1274-81.
-
Jiang C, Atkinson D, Towbin JA, Splawski I, Lehmann MH, Li H, Timothy K, Taggart RT, Schwartz PJ, Vincent GM, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet. 1994 Oct; 8(2):141-7.
-
Gottlieb S, Moss AJ, McDermott M, Eberly S. Comparison of posthospital survival after acute myocardial infarction in women and men. Am J Cardiol. 1994 Oct 1; 74(7):727-30.
-
Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q-wave and Q-wave myocardial infarction: the limited role of non-invasive testing. Coron Artery Dis. 1994 Oct; 5(10):857-64.
-
Zareba W, Moss AJ, le Cessie S. Dispersion of ventricular repolarization and arrhythmic cardiac death in coronary artery disease. Am J Cardiol. 1994 Sep 15; 74(6):550-3.
-
Moss AJ, Zareba W. Principles underlying the use of Holter monitoring to define the efficacy of antiarrhythmic drugs. Coron Artery Dis. 1994 Aug; 5(8):665-70.
-
Gottlieb S, Fallavollita J, McDermott M, Brown M, Eberly S, Moss AJ. Cigarette smoking and the age at onset of a first non-fatal myocardial infarction. Coron Artery Dis. 1994 Aug; 5(8):687-94.
-
Bodenheimer MM, Sauer D, Shareef B, Brown MW, Fleiss JL, Moss AJ. Relation between myocardial infarct location and stroke. J Am Coll Cardiol. 1994 Jul; 24(1):61-6.
-
Moss A, Fryer JP, Leventhal JR, Simone P, Chen S, Reinsmoen N, Matas AJ. Analysis of the human anti-pig cellular immune response using the Hu-scid mouse-porcine skin graft model. Transplant Proc. 1994 Jun; 26(3):1209.
-
The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Circulation. 1994 Jun; 89(6):2892-907.
-
Zareba W, Moss AJ, le Cessie S, Hall WJ. T wave alternans in idiopathic long QT syndrome. J Am Coll Cardiol. 1994 Jun; 23(7):1541-6.
-
Boden WE, Moss AJ, Herbert PN, Saritelli A, Oakes D, Eberly S. Effect of long-term diltiazem administration on serum lipids in post-myocardial infarction survivors. Multicenter Diltiazem Post-Infarction Trial Research Group. Am J Cardiol. 1994 Mar 1; 73(7):513-4.
-
Zareba W, Badilini F, Moss AJ. Automatic detection of spatial and dynamic heterogeneity of repolarization. J Electrocardiol. 1994; 27 Suppl:66-72.
-
Merri M, Alberti M, Moss AJ. Dynamic analysis of ventricular repolarization duration from 24-hour Holter recordings. IEEE Trans Biomed Eng. 1993 Dec; 40(12):1219-25.
-
Moss AJ. Sudden cardiac death and national health. Pacing Clin Electrophysiol. 1993 Nov; 16(11):2190-1.
-
Moss AJ. Influence of the implantable cardioverter defibrillator on survival: retrospective studies and prospective trials. Prog Cardiovasc Dis. 1993 Sep-Oct; 36(2):85-8.
-
Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993 Aug 26; 72(6):23B-25B.
-
Curran M, Atkinson D, Timothy K, Vincent GM, Moss AJ, Leppert M, Keating M. Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest. 1993 Aug; 92(2):799-803.
-
Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993 Aug; 88(2):782-4.
-
Moss AJ, Goldstein RE, Hall WJ, Bigger JT, Fleiss JL, Greenberg H, Bodenheimer M, Krone RJ, Marcus FI, Wackers FJ, et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. Multicenter Myocardial Ischemia Research Group. JAMA. 1993 May 12; 269(18):2379-85.
-
Moss AJ. One randomized defibrillator trial is worth 1,000 descriptive reports. Pacing Clin Electrophysiol. 1993 Feb; 16(2):247-50.
-
Shammas NW, Moss AJ, Sullebarger JT, Gutierrez OH, Rocco TA. Acquired coronary angiogenesis after myocardial infarction. Cardiology. 1993; 83(3):212-6.
-
Moss AJ. Asymptomatic ventricular arrhythmias in healthy persons: smoke or smoke screen? Ann Intern Med. 1992 Dec 15; 117(12):1053-4.
-
Sweeney MO, Moss AJ, Eberly S. Instantaneous cardiac death in the posthospital period after acute myocardial infarction. Am J Cardiol. 1992 Dec 1; 70(18):1375-9.
-
Moss AJ. Prevention of sudden cardiac death. Hosp Pract (Off Ed). 1992 Nov 15; 27(11):165-8, 173-6.
-
Moss AJ. Molecular genetics and ventricular arrhythmias. N Engl J Med. 1992 Sep 17; 327(12):885-7.
-
Moss AJ. Q-wave vs non-Q-wave myocardial infarction. An oversimplified dichotomy. JAMA. 1992 Sep 23-30; 268(12):1595-6.
-
Moss AJ, Robinson JL. Long QT syndrome. Heart Dis Stroke. 1992 Sep-Oct; 1(5):309-14.
-
Cobb LA, Eliastam M, Kerber RE, Melker R, Moss AJ, Newell L, Paraskos JA, Weaver WD, Weil M, Weisfeldt ML. Report of the American Heart Association Task Force on the Future of Cardiopulmonary Resuscitation. Circulation. 1992 Jun; 85(6):2346-55.
-
Boden WE, Moss AJ, Oakes D. Hypolipidemic effect of type Ia antiarrhythmic agents in postinfarction patients. Circulation. 1992 Jun; 85(6):2039-44.
-
Merri M, Moss AJ, Benhorin J, Locati EH, Alberti M, Badilini F. Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings. Findings in normal patients and patients with long QT syndrome. Circulation. 1992 May; 85(5):1816-21.
-
Moss AJ, Robinson JL. The long-QT syndrome Genetic considerations. Trends Cardiovasc Med. 1992 May-Jun; 2(3):81-3.
-
Weissmann P, Chin MT, Moss AJ. Cardiac tachypacing for severe refractory idiopathic orthostatic hypotension. Ann Intern Med. 1992 Apr 15; 116(8):650-1.
-
Gottlieb S, Moss AJ, McDermott M, Eberly S. Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction. Am J Cardiol. 1992 Apr 15; 69(12):977-84.
-
Moss AJ. Clues in diagnosing congenital heart disease. West J Med. 1992 Apr; 156(4):392-8.
-
Moss AJ. Prospective antiarrhythmic studies assessing prophylactic pharmacological and device therapy in high risk coronary patients. Pacing Clin Electrophysiol. 1992 Apr; 15(4 Pt 3):694-6.
-
Moss AJ, Robinson JL. Clinical aspects of the idiopathic long QT syndrome. Ann N Y Acad Sci. 1992 Jan 27; 644:103-11.
-
Moss AJ, Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation. 1992 Jan; 85(1 Suppl):I140-4.
-
Connery CP, DeWeese JA, Eisenberg BK, Moss AJ. Treatment of aortic coarctation by axillofemoral bypass grafting in the high-risk patient. Ann Thorac Surg. 1991 Dec; 52(6):1281-4.
-
Moss AJ, Liu JE, Gottlieb S, Locati EH, Schwartz PJ, Robinson JL. Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome. Circulation. 1991 Oct; 84(4):1524-9.
-
Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation. 1991 Sep; 84(3):1136-44.
-
Moss AJ, Oakes D, Rubison M, McDermott M, Carleen E, Eberly S, Brown M. Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group. Am J Cardiol. 1991 Aug 15; 68(5):429-33.
-
Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome. A worldwide report. Circulation. 1991 Aug; 84(2):503-11.
-
Multicenter automatic defibrillator implantation trial (MADIT): design and clinical protocol. MADIT Executive Committee. Pacing Clin Electrophysiol. 1991 May; 14(5 Pt 2):920-7.
-
Kastor JA, Moss AJ, Mower MM, Weisfeldt ML. Michel Mirowski: a man with a mission. Pacing Clin Electrophysiol. 1991 May; 14(5 Pt 2):864-5.
-
Moss AJ. Pathophysiologic factors influencing prognosis after myocardial infarction. J Cardiovasc Pharmacol. 1991; 18 Suppl 2:S83-6.
-
Moxley RT, Arner P, Moss A, Skottner A, Fox M, James D, Livingston JN. Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo. Am J Physiol. 1990 Oct; 259(4 Pt 1):E561-7.
-
Benhorin J, Merri M, Alberti M, Locati E, Moss AJ, Hall WJ, Cui L. Long QT syndrome. New electrocardiographic characteristics. Circulation. 1990 Aug; 82(2):521-7.
-
Moss AJ. Identification of patients at increased risk for potentially malignant arrhythmias. Cardiovasc Drugs Ther. 1990 Jun; 4(3):665-7.
-
Benhorin J, Moss AJ, Oakes D, Marcus F, Greenberg H, Dwyer EM, Algeo S, Hahn E. The prognostic significance of first myocardial infarction type (Q wave versus non-Q wave) and Q wave location. The Multicenter Diltiazem Post-Infarction Research Group. J Am Coll Cardiol. 1990 May; 15(6):1201-7.
-
Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med. 1990 Mar 15; 322(11):743-53.
-
Gilpin EA, Olshen RA, Chatterjee K, Kjekshus J, Moss AJ, Henning H, Engler R, Blacky AR, Dittrich H, Ross J. Predicting 1-year outcome following acute myocardial infarction: physicians versus computers. Comput Biomed Res. 1990 Feb; 23(1):46-63.
-
Fleiss JL, Bigger JT, McDermott M, Miller JP, Moon T, Moss AJ, Oakes D, Rolnitzky LM, Therneau TM. Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology. Circulation. 1990 Feb; 81(2):684-5.
-
Benhorin J, Moss AJ, Oakes D. Prognostic significance of nonfatal myocardial reinfarction. Multicenter Diltiazem Postinfarction Trial Research Group. J Am Coll Cardiol. 1990 Feb; 15(2):253-8.
-
Moss AJ, Merri M, Benhorin J, Alberti M, Locati E. Multidimensional quantitation of ventricular repolarization. Static and dynamic characteristics. Ann N Y Acad Sci. 1990; 601:31-5.
-
Merri M, Alberti M, Benhorin J, Moss AJ. Preprocessing of Holter ECGs for analysis of the dynamic interrelations between heart rate and ventricular repolarization duration variabilities. J Electrocardiol. 1990; 23 Suppl:157-62.
-
Moss AJ, Oakes D, Benhorin J, Carleen E. The interaction between diltiazem and left ventricular function after myocardial infarction. Multicenter Diltiazem Post-Infarction Research Group. Circulation. 1989 Dec; 80(6 Suppl):IV102-6.
-
Merri M, Benhorin J, Alberti M, Locati E, Moss AJ. Electrocardiographic quantitation of ventricular repolarization. Circulation. 1989 Nov; 80(5):1301-8.
-
Moss AJ. Extraction of physiologic cardiac data from Holter recordings. Isr J Med Sci. 1989 Sep; 25(9):513-6.
-
Unger J, McNeill TH, Moxley RT, White M, Moss A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience. 1989; 31(1):143-57.
-
Gonda RL, Gutierrez OH, Moss AJ, Lee HJ. Multiple coronary artery-left ventricular fistulas: a pattern of anomalous coronary microvascularization. Cardiovasc Intervent Radiol. 1988 Dec; 11(6):313-8.
-
Benhorin J, Andrews ML, Carleen ED, Moss AJ. Occurrence, characteristics and prognostic significance of early postacute myocardial infarction angina pectoris. Am J Cardiol. 1988 Oct 1; 62(10 Pt 1):679-85.
-
The effect of diltiazem on mortality and reinfarction after myocardial infarction. The Multicenter Diltiazem Postinfarction Trial Research Group. N Engl J Med. 1988 Aug 18; 319(7):385-92.
-
McNamara RF, Carleen E, Moss AJ. Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. Am J Cardiol. 1988 Aug 1; 62(4):192-6.
-
Marcus FI, Cobb LA, Edwards JE, Kuller L, Moss AJ, Bigger JT, Fleiss JL, Rolnitzky L, Serokman R. Mechanism of death and prevalence of myocardial ischemic symptoms in the terminal event after acute myocardial infarction. Am J Cardiol. 1988 Jan 1; 61(1):8-15.
-
The mortality risk associated with digitalis treatment after myocardial infarction. The Digitalis Subcommittee of the Multicenter Post-Infarction Research Group. Cardiovasc Drugs Ther. 1987 Aug; 1(2):125-32.
-
Moss AJ, Bigger JT, Odoroff CL. Postinfarct risk stratification. Prog Cardiovasc Dis. 1987 May-Jun; 29(6):389-412.
-
Kleiger RE, Miller JP, Bigger JT, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987 Feb 1; 59(4):256-62.
-
Moss AJ. Prolonged QT-interval syndromes. JAMA. 1986 Dec 5; 256(21):2985-7.
-
Gillespie JA, Moss AJ. Postinfarction risk profiling: past, present and future considerations. J Am Coll Cardiol. 1986 Jul; 8(1):50-1.
-
Gramiak R, Holen J, Moss AJ, Gutierrez OH, Picone AL, Roe SA. Left coronary arterial blood flow: noninvasive detection by Doppler US. Radiology. 1986 Jun; 159(3):657-62.
-
Moss AJ. Current status of calcium channel blocking drugs after myocardial infarction. Eur Heart J. 1986 May; 7 Suppl A:31-4.
-
DeBusk RF, Blomqvist CG, Kouchoukos NT, Luepker RV, Miller HS, Moss AJ, Pollock ML, Reeves TJ, Selvester RH, Stason WB, et al. Identification and treatment of low-risk patients after acute myocardial infarction and coronary-artery bypass graft surgery. N Engl J Med. 1986 Jan 16; 314(3):161-6.
-
Case RB, Heller SS, Case NB, Moss AJ. Type A behavior and survival after acute myocardial infarction. N Engl J Med. 1985 Mar 21; 312(12):737-41.
-
Moss AJ. Caution: very-low-calorie diets can be deadly. Ann Intern Med. 1985 Jan; 102(1):121-3.
-
Krone RJ, Gillespie JA, Weld FM, Miller JP, Moss AJ. Low-level exercise testing after myocardial infarction: usefulness in enhancing clinical risk stratification. Circulation. 1985 Jan; 71(1):80-9.
-
Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E. The long QT syndrome: a prospective international study. Circulation. 1985 Jan; 71(1):17-21.
-
Greenberg H, McMaster P, Dwyer EM. Left ventricular dysfunction after acute myocardial infarction: results of a prospective multicenter study. J Am Coll Cardiol. 1984 Nov; 4(5):867-74.
-
Dwyer EM, McMaster P, Greenberg H. Nonfatal cardiac events and recurrent infarction in the year after acute myocardial infarction. J Am Coll Cardiol. 1984 Oct; 4(4):695-702.
-
Moss AJ. Atrial fibrillation and cerebral embolism. Arch Neurol. 1984 Jul; 41(7):707.
-
Moss AJ. Caution: digitalis may be injurious to post-infarction patients. Int J Cardiol. 1984 Jul; 6(1):95-8.
-
Moss AJ. Early identification of patients who may require electrical control treatment. Pacing Clin Electrophysiol. 1984 May; 7(3 Pt 2):493-8.
-
Wilson PC, Gutierrez O, Moss A. Early evaluation of coronary artery bypass grafts: CT or selective angiography. Eur J Radiol. 1984 Feb; 4(1):22-7.
-
Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984 Feb; 69(2):250-8.
-
Moss AJ. Update of postinfarction-risk stratification: physiologic variables. Ann N Y Acad Sci. 1984; 427:280-5.
-
Moss AJ. Clinical trials in the evaluation of antiarrhythmic drugs: design, drugs, and double-blind considerations. Ann N Y Acad Sci. 1984; 432:103-7.
-
Moss AJ. Prognosis after myocardial infarction. Am J Cardiol. 1983 Oct 1; 52(7):667-9.
-
Risk stratification and survival after myocardial infarction. N Engl J Med. 1983 Aug 11; 309(6):331-6.
-
Moss AJ, Schwartz PJ. Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. Mod Concepts Cardiovasc Dis. 1982 Mar; 51(3):85-90.
-
Moss AJ. Postinfarction therapy with beta blockers: who should be treated? Int J Cardiol. 1982; 1(5-6):343-9.
-
Moss AJ, Davis HT, Conard DL, DeCamilla JJ, Odoroff CL. Digitalis-associated cardiac mortality after myocardial infarction. Circulation. 1981 Dec; 64(6):1150-6.
-
Moss AJ. The platelet connection in arteriosclerotic disease. West J Med. 1981 Mar; 134(3):261-2.
-
Nagle WA, Moss AJ, Roberts HG, Baker ML. Effects of 5-thio-D-glucose on cellular adenosine triphosphate levels and deoxyribonucleic acid rejoining hy hypoxic and aerobic Chinese hamster cells. Radiology. 1980 Oct; 137(1 Pt 1):203-11.
-
Moss AJ. Clinical significance of ventricular arrhythmias in patients with and without coronary artery disease. Prog Cardiovasc Dis. 1980 Jul-Aug; 23(1):33-52.
-
DeSilvey DL, Moss AJ. Primidone in the treatment of the long QT syndrome: QT shortening and ventricular arrhythmia suppression. Ann Intern Med. 1980 Jul; 93(1):53-4.
-
Moss AJ, Glaser W, Topol E. Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension. N Engl J Med. 1980 Jun 26; 302(26):1456-7.
-
DeCamilla JJ, Davis HT, Moss AJ. Frequency and complexity of ventricular ectopic beats in the posthospital phase of myocardial infarction. J Electrocardiol. 1980 Apr; 13(2):125-34.
-
Moss AJ. Prediction and prevention of sudden cardiac death. Annu Rev Med. 1980; 31:1-14.
-
Moss AJ. Detection, significance and management of VPBs in ambulatory patients. Cardiovasc Clin. 1980; 11(1):143-58.
-
Davis HT, DeCamilla J, Bayer LW, Moss AJ. Survivorship patterns in the posthospital phase of myocardial infarction. Circulation. 1979 Dec; 60(6):1252-8.
-
Moss AJ, Davis HT, DeCamilla J, Bayer LW. Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction. Circulation. 1979 Nov; 60(5):998-1003.
-
Moss AJ. Factors influencing prognosis after myocardial infarction. Curr Probl Cardiol. 1979 Aug; 4(5):6-53.
-
Gershon ES, Goldstein RE, Moss AJ, van Kammen DP. Psychosis with ordinary doses of propranolol. Ann Intern Med. 1979 Jun; 90(6):938-9.
-
Moss AJ, Schwartz PJ. Sudden death and the idiopathic long Q-T syndrome. Am J Med. 1979 Jan; 66(1):6-7.
-
Anderson KP, DeCamilla J, Moss AJ. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation. 1978 May; 57(5):890-7.
-
Moss AJ. Classifying and evaluating syncope. Geriatrics. 1978 Feb; 33(2):103-14.
-
Moss AJ, Rivers RJ. Atrial pacing from the coronary vein. Ten-year experience in 50 patients with implanted pervenous pacemakers. Circulation. 1978 Jan; 57(1):103-6.
-
Moss AJ, DeCamilla J, Davis H. Cardiac Death in the first 6 months after myocardial infarction: potential for mortality reduction in the early posthospital period. Am J Cardiol. 1977 May 26; 39(6):816-20.
-
Moss AJ, DeCamilla JJ, Davis HP, Bayer L. Clinical significance of ventricular ectopic beats in the early posthospital phase of myocardial infarction. Am J Cardiol. 1977 May 4; 39(5):635-40.
-
Moss AJ, DeCamilla J, Davis H, Bayer L. The early posthospital phase of myocardial infarction. Prognostic stratification. Circulation. 1976 Jul; 54(1):58-64.
-
Erichsen EA, Baker ML, Moss AJ, Prior RM, Dalrymple GV. Survival of mouse L-929 cells following neutron irradiation. Radiology. 1976 May; 119(2):467-9.
-
Moss AJ, Baker ML, Prior RM, Erichsen EA, Nagle WA, Dalrymple GV. Fast neutron and x-ray induced single strand DNA breaks in cultured mammalian cells. Radiology. 1976 May; 119(2):459-61.
-
Prior RM, Moss AJ, Erichsen EA, Eason CS, Baker ML, Dalrymple GV. A fast neutron source for cultured cell irradiation. Radiology. 1976 May; 119(2):463-5.
-
Moss AJ. Editorial: Reduction of infarct size by oxygen inhalation. Ann Intern Med. 1975 Dec; 83(6):897-8.
-
Rodgers MV, Moss AJ, Hoffman M, Lipchik EO. Arteriovenous fistulae secondary to renal cell carcinoma. Clinical and cardiovascular manifestations: report of a case. Circulation. 1975 Aug; 52(2):345-50.
-
Moss AJ. Therapeutic uses of permanent pervenous atrial pacemakers: A review. J Electrocardiol. 1975; 8(4):373-80.
-
Moss AJ, Rivers RJ. Termination and inhibition of recurrent tachycardias by implanted pervenous pacemakers. Circulation. 1974 Nov; 50(5):942-7.
-
Moss AJ, Davis RJ. Brady-Tachy syndrome. Prog Cardiovasc Dis. 1974 Mar-Apr; 16(5):439-54.
-
Moss AJ, DeCamilla J, Engstrom F, Hoffman W, Odoroff C, Davis H. The posthospital phase of myocardial infarction: identification of patients with increased mortality risk. Circulation. 1974 Mar; 49(3):460-6.
-
Moss AJ, Rivers RJ, Kramer DH. Permanent pervenous atrial pacing from the coronary vein. Long-term follow-up. Circulation. 1974 Feb; 49(2):222-5.
-
Moss AJ, Rivers RJ, Kramer DH, Resnicoff S. Permanent pervenous atrial synchronized ventricular pacing. Circulation. 1973 Jul; 48(1):37-40.
-
Moss AJ. Implanted standby defibrillators. Circulation. 1973 May; 47(5):1135.
-
Stuard ID, Heusinkveld RS, Moss AJ. Microangiopathic hemolytic anemia and thrombocytopenia in primary pulmonary hypertension. N Engl J Med. 1972 Oct 26; 287(17):869-70.
-
Hemry DA, Moss AJ, Jacox RF. Relapsing polychondritis, a "floppy" mitral valve, and migratory polytendonitis. Ann Intern Med. 1972 Oct; 77(4):576-80.
-
Dalrymple GV, Riggs OE, Boyd CM, Sanders JL, Moss AJ, Baker ML, Nash JC, Wilkinson KP. In situ repair by human malignant cells of radiation-induced DNA breaks. Radiology. 1972 Aug; 104(2):415-8.
-
Greene WA, Goldstein S, Moss AJ. Psychosocial aspects of sudden death. A preliminary report. Arch Intern Med. 1972 May; 129(5):725-31.
-
Goldstein S, Moss AJ, Greene W. Sudden death in acute myocardial infarction. Relationship to factors affecting delay in hospitalization. Arch Intern Med. 1972 May; 129(5):720-4.
-
Moss AJ, Goldstein S, Greene W, DeCamilla J. Prehospital precursors of ventricular arrhythmias in acute myocardial infarction. Arch Intern Med. 1972 May; 129(5):756-62.
-
Moss AJ, Goldstein S. Symposium on the prehospital phase of acute myocardial infarction. Introduction. Arch Intern Med. 1972 May; 129(5):713.
-
Moss AJ, Schnitzler R, Green R, Decamilla J. Ventricular arrhythmias 3 weeks after acute myocardial infarction. Ann Intern Med. 1971 Dec; 75(6):837-41.
-
Moss AJ, McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med. 1971 Oct 14; 285(16):903-4.
-
Michaelson SM, Moss AJ. Environmental influences on implanted cardiac pacemakers. JAMA. 1971 Jun 21; 216(12):2006-7.
-
Moss AJ, Schenk EA. Cardiovascular effects of sustained norepinephrine infusions in dogs. IV. Previous treatment with adrenergic blocking agents. Circ Res. 1970 Dec; 27(6):1013-22.
-
Moss AJ, Johnson J. Effects of oxygen inhalation on intramyocardial oxygen tension. Cardiovasc Res. 1970 Oct; 4(4):436-40.
-
Moss AJ, Johnson J, Sentman J. Increase in myocardial oxygenation with propranolol. Cardiovasc Res. 1970 Oct; 4(4):441-2.
-
Moss AJ. Acute myocardial infarction. Pre-hospital and post-hospital consideration. Med Times. 1970 Sep; 98(9):81-91.
-
Kramer DH, Moss AJ. Permanent pervenous atrial pacing from the coronary vein. Circulation. 1970 Sep; 42(3):427-36.
-
Moss AJ, DeWeese J, Lipchick E, Olsan E. Combined septal rupture repair and infarctectomy in acute myocardial infarction. JAMA. 1970 Jul 20; 213(3):460-2.
-
Moss AJ, Goldstein S. The pre-hospital phase of acute myocadial infarction. Circulation. 1970 May; 41(5):737-42.
-
Hutter AM, Moss AJ. Central venous oxygen saturations. Value of serial determinations in patients with acute myocardial infarction. JAMA. 1970 Apr 13; 212(2):299-303.
-
Kramer DH, Moss AJ, Shah PM. Mechanisms and significance of pacemaker-induced extracardiac sound. Am J Cardiol. 1970 Mar; 25(3):367-71.
-
Moss AJ, Wynar B. Tachycardia in house officers presenting cases at grand rounds. Ann Intern Med. 1970 Feb; 72(2):255-6.
-
Goldstein S, Moss AJ, Rivers RJ, Weiner RS. Transthoracic and transvenous pacemakers. A comparative clinical experience with 131 implantable units. Br Heart J. 1970 Jan; 32(1):35-45.
-
Moss AJ, Hutter AM, Lipchik EO, Gallagher RE. Congenital corrected transposition of the great vessels without cardiac anomalies. Am J Med. 1969 Dec; 47(6):986-94.
-
Moss AJ, Wynar B, Goldstein S. Delay in hospitalization during the acute coronary period. Am J Cardiol. 1969 Nov; 24(5):659-65.
-
Goldstein S, Moss AJ. Symposium on the pre-hospital phase of acute myocardial infarction. I. Introduction. Am J Cardiol. 1969 Nov; 24(5):609-11.
-
Hayashi KD, Moss AJ, Yu PN. Urinary catecholamine excretion in myocardial infarction. Circulation. 1969 Oct; 40(4):473-81.
-
Lipchik EO, Roghair GD, Moss AJ, Rivers RJ. Importance of collateral vessel supply to internal mammary arteries in the treatment of ischemic heart disease. Am J Roentgenol Radium Ther Nucl Med. 1969 Oct; 107(2):361-5.
-
Moss AJ, Rivers RJ, Cooper M. Long-term pervenous atrial pacing from the proximal portion of the coronary vein. JAMA. 1969 Jul 28; 209(4):543-5.
-
Moss AJ, Minken SL, Samuelson P, Angell C. Effects of exogenous and endogenous norepinephrine on the oxygen availability of intact muscular arteries. J Atheroscler Res. 1969 Jul-Aug; 10(1):11-8.
-
Davis JM, Moss AJ, Schenk EA. Tricuspid candida endocarditis complicating a permanently implanted transvenous pacemaker. Am Heart J. 1969 Jun; 77(6):818-21.
-
Greene WA, Moss AJ. Psychosocial factors in the adjustment of patients with permanently implanted cardiac pacemakers. Ann Intern Med. 1969 May; 70(5):897-902.
-
Moss AJ, Harris DJ. Congenital herniation of the large bowel into the pericardial cavity. Survival into adulthood despite a generalized connective tissue disorder. Dis Chest. 1969 Apr; 55(4):301-5.
-
Moss AJ, Goldstein S. Clinical and pharmacological factors associated with pacemaker latency and incomplete pacemaker capture. Br Heart J. 1969 Jan; 31(1):112-7.
-
Moss AJ. Intramyocardial oxygen tension. Cardiovasc Res. 1968 Jul; 2(3):314-8.
-
Moss AJ, Rivers RJ, Griffith LS, Carmel JA, Millard EB. Transvenous left atrial pacing for the control of recurrent ventricular fibrillation. N Engl J Med. 1968 Apr 25; 278(17):928-31.
-
Kutner FR, Moss AJ. Effects of acute digitalization on cardiovascular dynamics in experimental, surgically induced heart block. Am Heart J. 1967 Jul; 74(1):71-6.
-
Norris FH, Moss AJ, Yu PN. On the possibility that a type of human muscular dystrophy commences in myocardium. Ann N Y Acad Sci. 1966 Sep 9; 138(1):342-55.
-
Moss AJ, Rivers R. Myocardial perforation by a permanent transvenous pacemaker. N Engl J Med. 1966 Aug 4; 275(5):265-6.
-
Moss AJ, Vittands I, Schenk EA. Cardiovascular effects of sustained norepinephrine infusions. 1. Hemodynamics. Circ Res. 1966 May; 18(5):596-604.
-
Schenk EA, Galbreath R, Moss AJ. Cardiovascular effects of sustained norepinephrine infusions. 3. Lactic dehydrogenase isoenzyme release. Circ Res. 1966 May; 18(5):616-9.
-
Schenk EA, Moss AJ. Cardiovascular effects of sustained norepinephrine infusions. II. Morphology. Circ Res. 1966 May; 18(5):605-15.
-
Moss AJ, Bruhn F. The echocardiogram. An ultrasound technic for the detection of pericardial effusion. N Engl J Med. 1966 Feb 17; 274(7):380-4.
-
Moss AJ, Aledort LM. Use of edrophonium (tensilon) in the evaluation of supraventricular tachycardias. Am J Cardiol. 1966 Jan; 17(1):58-62.
-
MOSS AJ, WATERHOUSE C, TERRY R. GLUTEN-SENSITIVE ENTEROPATHY WITH OSTEOMALACIA BUT WITHOUT STEATORRHEA. N Engl J Med. 1965 Apr 22; 272:825-30.
-
MOSS AJ, OSBORNE RK, BAUE AE, LEES RS, JAMISON RL, SPANN J. Closed-chest cardiac massage in the treatment of ventricular fibrillation complicating acute myocardial infarction. N Engl J Med. 1962 Oct 4; 267:679-81.
-
MOSS AJ. Ischemic heart disease and accelerated cardiovascular aging. A ballistocardiographic study. Circulation. 1962 Feb; 25:369-75.
-
MOSS AJ. Ballistocardiographic evaluation of the cardiovascular aging process. Circulation. 1961 Mar; 23:434-51.
-
MOSS AJ, BRADLEY BE. Ballistocardiographic response to hyperthermia. J Appl Physiol. 1960 May; 15:445-8.
-
MOSS AJ. The effect of hypoxia on the rate at which the cardiac ejection force is generated: a ballistocardiographic study. Am Heart J. 1960 Mar; 59:412-27.
|
Moss's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
